activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
Not Active	1650675	CHEMBL859485	Average Binding Constant for TNIK; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL4527	Homo sapiens	Kd		
Not Active	1650675	CHEMBL859485	Average Binding Constant for TNIK; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL4527	Homo sapiens	Kd		
	1650676	CHEMBL859485	Average Binding Constant for TNIK; NA=Not Active at 10 uM	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	45.0	CHEMBL4527	Homo sapiens	Kd	uM	0.045
Not Active	1650677	CHEMBL859485	Average Binding Constant for TNIK; NA=Not Active at 10 uM	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253		Kd			CHEMBL4527	Homo sapiens	Kd		
	1650678	CHEMBL859485	Average Binding Constant for TNIK; NA=Not Active at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	25.0	CHEMBL4527	Homo sapiens	Kd	uM	0.025
Not Active	1650679	CHEMBL859485	Average Binding Constant for TNIK; NA=Not Active at 10 uM	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660		Kd			CHEMBL4527	Homo sapiens	Kd		
	1650680	CHEMBL859485	Average Binding Constant for TNIK; NA=Not Active at 10 uM	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	5800.0	CHEMBL4527	Homo sapiens	Kd	uM	5.8
Not Active	1650681	CHEMBL859485	Average Binding Constant for TNIK; NA=Not Active at 10 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336		Kd			CHEMBL4527	Homo sapiens	Kd		
Not Active	1650682	CHEMBL859485	Average Binding Constant for TNIK; NA=Not Active at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762		Kd			CHEMBL4527	Homo sapiens	Kd		
Not Active	1650683	CHEMBL859485	Average Binding Constant for TNIK; NA=Not Active at 10 uM	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690		Kd			CHEMBL4527	Homo sapiens	Kd		
	1651599	CHEMBL859485	Average Binding Constant for TNIK; NA=Not Active at 10 uM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	6.0	CHEMBL4527	Homo sapiens	Kd	uM	0.006
	1651600	CHEMBL859485	Average Binding Constant for TNIK; NA=Not Active at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	uM	10.0
	1651601	CHEMBL859485	Average Binding Constant for TNIK; NA=Not Active at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Kd	nM	1500.0	CHEMBL4527	Homo sapiens	Kd	uM	1.5
Not Active	1651602	CHEMBL859485	Average Binding Constant for TNIK; NA=Not Active at 10 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385		Kd			CHEMBL4527	Homo sapiens	Kd		
	1651603	CHEMBL859485	Average Binding Constant for TNIK; NA=Not Active at 10 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	9.9	CHEMBL4527	Homo sapiens	Kd	uM	0.0099
	1651604	CHEMBL859485	Average Binding Constant for TNIK; NA=Not Active at 10 uM	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Kd	nM	480.0	CHEMBL4527	Homo sapiens	Kd	uM	0.48
Not Active	1651605	CHEMBL859485	Average Binding Constant for TNIK; NA=Not Active at 10 uM	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		Kd			CHEMBL4527	Homo sapiens	Kd		
Not Active	1651606	CHEMBL859485	Average Binding Constant for TNIK; NA=Not Active at 10 uM	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939		Kd			CHEMBL4527	Homo sapiens	Kd		
Not Active	1651607	CHEMBL859485	Average Binding Constant for TNIK; NA=Not Active at 10 uM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553		Kd			CHEMBL4527	Homo sapiens	Kd		
	1651608	CHEMBL859485	Average Binding Constant for TNIK; NA=Not Active at 10 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	3900.0	CHEMBL4527	Homo sapiens	Kd	uM	3.9
Not Active	1651609	CHEMBL859485	Average Binding Constant for TNIK; NA=Not Active at 10 uM	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965		Kd			CHEMBL4527	Homo sapiens	Kd		
	2206873	CHEMBL990548	Inhibition of TNIK	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	25.0	CHEMBL4527	Homo sapiens	Kd	nM	25.0
	2470415	CHEMBL981797	Inhibition of TNIK at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL4527	Homo sapiens	INH	%	10.0
Not Evaluated	2476770	CHEMBL992629	Binding affinity to human TNIK at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL4527	Homo sapiens	Activity		
	2477862	CHEMBL986212	Binding affinity to human TNIK	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312	=	Kd	nM	160.0	CHEMBL4527	Homo sapiens	Kd	nM	160.0
Not Evaluated	2478609	CHEMBL992629	Binding affinity to human TNIK at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL4527	Homo sapiens	Activity		
	2478812	CHEMBL992629	Binding affinity to human TNIK at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755	=	Activity	%	0.3	CHEMBL4527	Homo sapiens	Activity	%	0.3
	2479667	CHEMBL992629	Binding affinity to human TNIK at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312	=	Activity	%	0.6	CHEMBL4527	Homo sapiens	Activity	%	0.6
	2479870	CHEMBL992629	Binding affinity to human TNIK at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Activity	%	4.8	CHEMBL4527	Homo sapiens	Activity	%	4.8
Active	2480667	CHEMBL992629	Binding affinity to human TNIK at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409		Activity			CHEMBL4527	Homo sapiens	Activity		
	2558441	CHEMBL989985	Inhibition of TNIK	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	IC50	nM	10000.0	CHEMBL4527	Homo sapiens	IC50	uM	10.0
Not Evaluated	2577288	CHEMBL992629	Binding affinity to human TNIK at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL4527	Homo sapiens	Activity		
	2577491	CHEMBL992629	Binding affinity to human TNIK at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337	=	Activity	%	3.7	CHEMBL4527	Homo sapiens	Activity	%	3.7
	2593493	CHEMBL992629	Binding affinity to human TNIK at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	12.2	CHEMBL4527	Homo sapiens	Activity	%	12.2
	2593696	CHEMBL992629	Binding affinity to human TNIK at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097	=	Activity	%	0.7	CHEMBL4527	Homo sapiens	Activity	%	0.7
	2593962	CHEMBL992629	Binding affinity to human TNIK at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519	=	Activity	%	0.7	CHEMBL4527	Homo sapiens	Activity	%	0.7
Not Evaluated	2594905	CHEMBL992629	Binding affinity to human TNIK at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL4527	Homo sapiens	Activity		
Not Evaluated	2595108	CHEMBL992629	Binding affinity to human TNIK at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL4527	Homo sapiens	Activity		
	2595174	CHEMBL992629	Binding affinity to human TNIK at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466	=	Activity	%	4.9	CHEMBL4527	Homo sapiens	Activity	%	4.9
	2596305	CHEMBL992629	Binding affinity to human TNIK at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342	=	Activity	%	1.6	CHEMBL4527	Homo sapiens	Activity	%	1.6
	2597574	CHEMBL992629	Binding affinity to human TNIK at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019	=	Activity	%	1.5	CHEMBL4527	Homo sapiens	Activity	%	1.5
	2597777	CHEMBL992629	Binding affinity to human TNIK at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Activity	%	1.7	CHEMBL4527	Homo sapiens	Activity	%	1.7
	2892615	CHEMBL1062874	Binding constant for TNIK kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	uM	10.0
	2892616	CHEMBL1062874	Binding constant for TNIK kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	uM	10.0
	2892617	CHEMBL1062874	Binding constant for TNIK kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	69.0	CHEMBL4527	Homo sapiens	Kd	nM	69.0
	2892618	CHEMBL1062874	Binding constant for TNIK kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	uM	10.0
	2892619	CHEMBL1062874	Binding constant for TNIK kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	140.0	CHEMBL4527	Homo sapiens	Kd	nM	140.0
	2892620	CHEMBL1062874	Binding constant for TNIK kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	uM	10.0
	2892621	CHEMBL1062874	Binding constant for TNIK kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	24.0	CHEMBL4527	Homo sapiens	Kd	nM	24.0
	2892622	CHEMBL1062874	Binding constant for TNIK kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	=	Kd	nM	1500.0	CHEMBL4527	Homo sapiens	Kd	nM	1500.0
	2892623	CHEMBL1062874	Binding constant for TNIK kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	uM	10.0
	2892624	CHEMBL1062874	Binding constant for TNIK kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	uM	10.0
	2892625	CHEMBL1062874	Binding constant for TNIK kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	uM	10.0
	2892626	CHEMBL1062874	Binding constant for TNIK kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	2000.0	CHEMBL4527	Homo sapiens	Kd	nM	2000.0
	2892627	CHEMBL1062874	Binding constant for TNIK kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	170.0	CHEMBL4527	Homo sapiens	Kd	nM	170.0
	2892628	CHEMBL1062874	Binding constant for TNIK kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	uM	10.0
	2892629	CHEMBL1062874	Binding constant for TNIK kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	uM	10.0
	2892630	CHEMBL1062874	Binding constant for TNIK kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	uM	10.0
	2892631	CHEMBL1062874	Binding constant for TNIK kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	uM	10.0
	2892632	CHEMBL1062874	Binding constant for TNIK kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	310.0	CHEMBL4527	Homo sapiens	Kd	nM	310.0
	2892633	CHEMBL1062874	Binding constant for TNIK kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	uM	10.0
	2892634	CHEMBL1062874	Binding constant for TNIK kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	uM	10.0
	2892635	CHEMBL1062874	Binding constant for TNIK kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	uM	10.0
	2892636	CHEMBL1062874	Binding constant for TNIK kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	uM	10.0
	2892637	CHEMBL1062874	Binding constant for TNIK kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	uM	10.0
	2892638	CHEMBL1062874	Binding constant for TNIK kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	uM	10.0
	2892639	CHEMBL1062874	Binding constant for TNIK kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	uM	10.0
	2892640	CHEMBL1062874	Binding constant for TNIK kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	1600.0	CHEMBL4527	Homo sapiens	Kd	nM	1600.0
	2892641	CHEMBL1062874	Binding constant for TNIK kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	uM	10.0
	2892642	CHEMBL1062874	Binding constant for TNIK kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	uM	10.0
	2892643	CHEMBL1062874	Binding constant for TNIK kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Kd	nM	1600.0	CHEMBL4527	Homo sapiens	Kd	nM	1600.0
	2892644	CHEMBL1062874	Binding constant for TNIK kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Kd	nM	820.0	CHEMBL4527	Homo sapiens	Kd	nM	820.0
	2892645	CHEMBL1062874	Binding constant for TNIK kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	uM	10.0
	2892646	CHEMBL1062874	Binding constant for TNIK kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	uM	10.0
	2892647	CHEMBL1062874	Binding constant for TNIK kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	4.7	CHEMBL4527	Homo sapiens	Kd	nM	4.7
	2892648	CHEMBL1062874	Binding constant for TNIK kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	90.0	CHEMBL4527	Homo sapiens	Kd	nM	90.0
	2892649	CHEMBL1062874	Binding constant for TNIK kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	25.0	CHEMBL4527	Homo sapiens	Kd	nM	25.0
	2892650	CHEMBL1062874	Binding constant for TNIK kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	1800.0	CHEMBL4527	Homo sapiens	Kd	nM	1800.0
	2892651	CHEMBL1062874	Binding constant for TNIK kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	uM	10.0
	2892652	CHEMBL1062874	Binding constant for TNIK kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	2300.0	CHEMBL4527	Homo sapiens	Kd	nM	2300.0
	2922022	CHEMBL1059381	Inhibition of TNIK assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	100.0	CHEMBL4527	Homo sapiens	Activity	%	100.0
	3333193	CHEMBL1168132	Inhibition of TNIK at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL4527	Homo sapiens	INH	%	50.0
	3334598	CHEMBL1168132	Inhibition of TNIK at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL4527	Homo sapiens	INH	%	50.0
	3335000	CHEMBL1168132	Inhibition of TNIK at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL4527	Homo sapiens	INH	%	50.0
	3336420	CHEMBL1168132	Inhibition of TNIK at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	=	Inhibition	%	82.0	CHEMBL4527	Homo sapiens	INH	%	82.0
	3337664	CHEMBL1168132	Inhibition of TNIK at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL4527	Homo sapiens	INH	%	50.0
	3338995	CHEMBL1168132	Inhibition of TNIK at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL4527	Homo sapiens	INH	%	50.0
	3339251	CHEMBL1168132	Inhibition of TNIK at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL4527	Homo sapiens	INH	%	50.0
	3340556	CHEMBL1168132	Inhibition of TNIK at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL4527	Homo sapiens	INH	%	50.0
	3341962	CHEMBL1168132	Inhibition of TNIK at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL4527	Homo sapiens	INH	%	50.0
	3343409	CHEMBL1168132	Inhibition of TNIK at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL4527	Homo sapiens	INH	%	50.0
	3351786	CHEMBL1175100	Inhibition of TNIK at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	1.6	CHEMBL4527	Homo sapiens	INH	%	1.6
	3358838	CHEMBL1175100	Inhibition of TNIK at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	1.8	CHEMBL4527	Homo sapiens	INH	%	1.8
Not Active	3446226	CHEMBL1244366	Inhibition of TNIK	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441		IC50			CHEMBL4527	Homo sapiens	IC50		
	3448653	CHEMBL1245006	Binding affinity to TNIK	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	uM	10.0
	3448810	CHEMBL1245006	Binding affinity to TNIK	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	5.4	CHEMBL4527	Homo sapiens	Kd	nM	5.4
	3449062	CHEMBL1245006	Binding affinity to TNIK	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	1600.0	CHEMBL4527	Homo sapiens	Kd	nM	1600.0
	3449364	CHEMBL1245006	Binding affinity to TNIK	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	25.0	CHEMBL4527	Homo sapiens	Kd	nM	25.0
	3449878	CHEMBL1245006	Binding affinity to TNIK	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	uM	10.0
	3450262	CHEMBL1245006	Binding affinity to TNIK	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	uM	10.0
	3451171	CHEMBL1245006	Binding affinity to TNIK	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	uM	10.0
	6341005	CHEMBL1827630	Activity of TNIK kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	99.0	CHEMBL4527	Homo sapiens	Activity	%	99.0
	7567510	CHEMBL1908790	Binding constant for TNIK kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	nM	10000.0
	7567981	CHEMBL1908790	Binding constant for TNIK kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	=	Kd	nM	140.0	CHEMBL4527	Homo sapiens	Kd	nM	140.0
	7568449	CHEMBL1908790	Binding constant for TNIK kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	430.0	CHEMBL4527	Homo sapiens	Kd	nM	430.0
	7568881	CHEMBL1908790	Binding constant for TNIK kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	90.0	CHEMBL4527	Homo sapiens	Kd	nM	90.0
	7569024	CHEMBL1908790	Binding constant for TNIK kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Kd	nM	810.0	CHEMBL4527	Homo sapiens	Kd	nM	810.0
	7569484	CHEMBL1908790	Binding constant for TNIK kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	nM	10000.0
	7569956	CHEMBL1908790	Binding constant for TNIK kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	nM	10000.0
	7570419	CHEMBL1908790	Binding constant for TNIK kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	=	Kd	nM	310.0	CHEMBL4527	Homo sapiens	Kd	nM	310.0
	7570846	CHEMBL1908790	Binding constant for TNIK kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	25.0	CHEMBL4527	Homo sapiens	Kd	nM	25.0
	7571000	CHEMBL1908790	Binding constant for TNIK kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	nM	10000.0
	7571457	CHEMBL1908790	Binding constant for TNIK kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	nM	10000.0
	7571933	CHEMBL1908790	Binding constant for TNIK kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	nM	10000.0
	7572396	CHEMBL1908790	Binding constant for TNIK kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	nM	10000.0
	7572812	CHEMBL1908790	Binding constant for TNIK kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	1200.0	CHEMBL4527	Homo sapiens	Kd	nM	1200.0
	7572981	CHEMBL1908790	Binding constant for TNIK kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	nM	10000.0
	7573438	CHEMBL1908790	Binding constant for TNIK kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	2000.0	CHEMBL4527	Homo sapiens	Kd	nM	2000.0
	7573914	CHEMBL1908790	Binding constant for TNIK kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	150.0	CHEMBL4527	Homo sapiens	Kd	nM	150.0
	7574959	CHEMBL1908790	Binding constant for TNIK kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	53.0	CHEMBL4527	Homo sapiens	Kd	nM	53.0
	7575420	CHEMBL1908790	Binding constant for TNIK kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	4500.0	CHEMBL4527	Homo sapiens	Kd	nM	4500.0
	7575891	CHEMBL1908790	Binding constant for TNIK kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	=	Kd	nM	2300.0	CHEMBL4527	Homo sapiens	Kd	nM	2300.0
	7575914	CHEMBL1908790	Binding constant for TNIK kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	1600.0	CHEMBL4527	Homo sapiens	Kd	nM	1600.0
	7576322	CHEMBL1908790	Binding constant for TNIK kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	nM	10000.0
	7576933	CHEMBL1908790	Binding constant for TNIK kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	nM	10000.0
	7577392	CHEMBL1908790	Binding constant for TNIK kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	210.0	CHEMBL4527	Homo sapiens	Kd	nM	210.0
	7577898	CHEMBL1908790	Binding constant for TNIK kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	=	Kd	nM	2500.0	CHEMBL4527	Homo sapiens	Kd	nM	2500.0
	7578303	CHEMBL1908790	Binding constant for TNIK kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	nM	10000.0
	7578941	CHEMBL1908790	Binding constant for TNIK kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	=	Kd	nM	140.0	CHEMBL4527	Homo sapiens	Kd	nM	140.0
	7579315	CHEMBL1908790	Binding constant for TNIK kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	140.0	CHEMBL4527	Homo sapiens	Kd	nM	140.0
	7579797	CHEMBL1908790	Binding constant for TNIK kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	28.0	CHEMBL4527	Homo sapiens	Kd	nM	28.0
	7580266	CHEMBL1908790	Binding constant for TNIK kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	270.0	CHEMBL4527	Homo sapiens	Kd	nM	270.0
	7580669	CHEMBL1908790	Binding constant for TNIK kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	2300.0	CHEMBL4527	Homo sapiens	Kd	nM	2300.0
	7581299	CHEMBL1908790	Binding constant for TNIK kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	nM	10000.0
	7581684	CHEMBL1908790	Binding constant for TNIK kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	nM	10000.0
	7581687	CHEMBL1908790	Binding constant for TNIK kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	nM	10000.0
	7582158	CHEMBL1908790	Binding constant for TNIK kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	nM	10000.0
	7582622	CHEMBL1908790	Binding constant for TNIK kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	nM	10000.0
	7583022	CHEMBL1908790	Binding constant for TNIK kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	1800.0	CHEMBL4527	Homo sapiens	Kd	nM	1800.0
	7584045	CHEMBL1908790	Binding constant for TNIK kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	=	Kd	nM	2300.0	CHEMBL4527	Homo sapiens	Kd	nM	2300.0
	7584516	CHEMBL1908790	Binding constant for TNIK kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	nM	10000.0
	7584978	CHEMBL1908790	Binding constant for TNIK kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	1300.0	CHEMBL4527	Homo sapiens	Kd	nM	1300.0
	7585382	CHEMBL1908790	Binding constant for TNIK kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	nM	10000.0
	7585533	CHEMBL1908790	Binding constant for TNIK kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	2800.0	CHEMBL4527	Homo sapiens	Kd	nM	2800.0
	7585941	CHEMBL1908790	Binding constant for TNIK kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	nM	10000.0
	7586387	CHEMBL1908790	Binding constant for TNIK kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	nM	10000.0
	7586858	CHEMBL1908790	Binding constant for TNIK kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	nM	10000.0
	7587312	CHEMBL1908790	Binding constant for TNIK kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	nM	10000.0
	7587494	CHEMBL1908790	Binding constant for TNIK kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	2800.0	CHEMBL4527	Homo sapiens	Kd	nM	2800.0
	7587913	CHEMBL1908790	Binding constant for TNIK kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	=	Kd	nM	160.0	CHEMBL4527	Homo sapiens	Kd	nM	160.0
	7588366	CHEMBL1908790	Binding constant for TNIK kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Kd	nM	6900.0	CHEMBL4527	Homo sapiens	Kd	nM	6900.0
	7588837	CHEMBL1908790	Binding constant for TNIK kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	nM	10000.0
	7589288	CHEMBL1908790	Binding constant for TNIK kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Kd	nM	820.0	CHEMBL4527	Homo sapiens	Kd	nM	820.0
	7589459	CHEMBL1908790	Binding constant for TNIK kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Kd	nM	180.0	CHEMBL4527	Homo sapiens	Kd	nM	180.0
	7589883	CHEMBL1908790	Binding constant for TNIK kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	5.4	CHEMBL4527	Homo sapiens	Kd	nM	5.4
	7590350	CHEMBL1908790	Binding constant for TNIK kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	nM	10000.0
	7590824	CHEMBL1908790	Binding constant for TNIK kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	nM	10000.0
	7591432	CHEMBL1908790	Binding constant for TNIK kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	nM	10000.0
	7591854	CHEMBL1908790	Binding constant for TNIK kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	24.0	CHEMBL4527	Homo sapiens	Kd	nM	24.0
	7592326	CHEMBL1908790	Binding constant for TNIK kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	nM	10000.0
	7592810	CHEMBL1908790	Binding constant for TNIK kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	nM	10000.0
	7593399	CHEMBL1908790	Binding constant for TNIK kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	69.0	CHEMBL4527	Homo sapiens	Kd	nM	69.0
	7593834	CHEMBL1908790	Binding constant for TNIK kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	=	Kd	nM	1500.0	CHEMBL4527	Homo sapiens	Kd	nM	1500.0
	7594306	CHEMBL1908790	Binding constant for TNIK kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	nM	10000.0
	7594337	CHEMBL1908790	Binding constant for TNIK kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	nM	10000.0
	7594789	CHEMBL1908790	Binding constant for TNIK kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	31.0	CHEMBL4527	Homo sapiens	Kd	nM	31.0
	7595367	CHEMBL1908790	Binding constant for TNIK kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	nM	10000.0
	7595811	CHEMBL1908790	Binding constant for TNIK kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	8200.0	CHEMBL4527	Homo sapiens	Kd	nM	8200.0
	7596314	CHEMBL1908790	Binding constant for TNIK kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	nM	10000.0
	7596761	CHEMBL1908790	Binding constant for TNIK kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	7900.0	CHEMBL4527	Homo sapiens	Kd	nM	7900.0
	7597339	CHEMBL1908790	Binding constant for TNIK kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	8500.0	CHEMBL4527	Homo sapiens	Kd	nM	8500.0
	7597823	CHEMBL1908790	Binding constant for TNIK kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4527	Homo sapiens	Kd	nM	10000.0
	7598293	CHEMBL1908790	Binding constant for TNIK kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	310.0	CHEMBL4527	Homo sapiens	Kd	nM	310.0
	7598735	CHEMBL1908790	Binding constant for TNIK kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	4.7	CHEMBL4527	Homo sapiens	Kd	nM	4.7
	8004360	CHEMBL1943332	Inhibition of human ZC2/TNIK in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940980	<	Inhibition	%	35.0	CHEMBL4527	Homo sapiens	INH	%	35.0
	8004361	CHEMBL1943332	Inhibition of human ZC2/TNIK in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940981	<	Inhibition	%	35.0	CHEMBL4527	Homo sapiens	INH	%	35.0
	8004362	CHEMBL1943332	Inhibition of human ZC2/TNIK in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940987	<	Inhibition	%	35.0	CHEMBL4527	Homo sapiens	INH	%	35.0
	8004363	CHEMBL1943332	Inhibition of human ZC2/TNIK in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940990	<	Inhibition	%	35.0	CHEMBL4527	Homo sapiens	INH	%	35.0
	8047179	CHEMBL1959408	Inhibition of TNIK at 1 uM	B	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4ccc5c(c4)OCCO5)s3)cc2)CC1		CHEMBL1956070	<	Inhibition	%	50.0	CHEMBL4527	Homo sapiens	INH	%	50.0
	12155955	CHEMBL2185153	Inhibition of KIAA0551 assessed as residual activity at 1000 nM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccnc4[nH]c(-c5ccccc5)cc34)[nH]2)cc1		CHEMBL2179119	=	Activity	%	17.0	CHEMBL4527	Homo sapiens	Activity	%	17.0
Active	12155958	CHEMBL2185153	Inhibition of KIAA0551 assessed as residual activity at 1000 nM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041		Inhibition	%		CHEMBL4527	Homo sapiens	INH		
	12172177	CHEMBL2209254	Inhibition of TNIK assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	74.0	CHEMBL4527	Homo sapiens	Activity	%	74.0
	12626647	CHEMBL2319997	Inhibition of TNIK-mediated TCF4/beta-casein transcription in human HCT116 cells by beta-lactamase reporter gene assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	39.0	CHEMBL4527	Homo sapiens	IC50	nM	39.0
	12626648	CHEMBL2319997	Inhibition of TNIK-mediated TCF4/beta-casein transcription in human HCT116 cells by beta-lactamase reporter gene assay	B	COc1ccc(C#N)cc1-c1ccnc(Nc2ccc(N3CCC(N(C)C)CC3)c(F)c2)c1		CHEMBL2312154	=	IC50	nM	3100.0	CHEMBL4527	Homo sapiens	IC50	nM	3100.0
	12626649	CHEMBL2319997	Inhibition of TNIK-mediated TCF4/beta-casein transcription in human HCT116 cells by beta-lactamase reporter gene assay	B	COc1ccc(C#N)cc1-c1ccnc(Nc2ccc(N3CCOCC3)c(OC)c2)c1		CHEMBL2312148	=	IC50	nM	6300.0	CHEMBL4527	Homo sapiens	IC50	nM	6300.0
	12626650	CHEMBL2319997	Inhibition of TNIK-mediated TCF4/beta-casein transcription in human HCT116 cells by beta-lactamase reporter gene assay	B	COc1ccc(C#N)cc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)c1		CHEMBL2312147	=	IC50	nM	26000.0	CHEMBL4527	Homo sapiens	IC50	nM	26000.0
	12626651	CHEMBL2319997	Inhibition of TNIK-mediated TCF4/beta-casein transcription in human HCT116 cells by beta-lactamase reporter gene assay	B	COc1ccc(Cl)cc1-c1ccnc(Nc2ccc(N3CCN(C)CC3)c(OC)c2)c1		CHEMBL2312145	=	IC50	nM	7900.0	CHEMBL4527	Homo sapiens	IC50	nM	7900.0
	12626652	CHEMBL2319997	Inhibition of TNIK-mediated TCF4/beta-casein transcription in human HCT116 cells by beta-lactamase reporter gene assay	B	COc1ccc(C#N)cc1-c1ccnc(Nc2ccc(N3CCN(C)CC3)cc2)c1		CHEMBL2312143	>	IC50	nM	30000.0	CHEMBL4527	Homo sapiens	IC50	nM	30000.0
	12626653	CHEMBL2319997	Inhibition of TNIK-mediated TCF4/beta-casein transcription in human HCT116 cells by beta-lactamase reporter gene assay	B	COc1cc(Nc2cc(-c3cccc(C#N)c3)ccn2)ccc1N1CCN(C)CC1		CHEMBL2312142	=	IC50	nM	27000.0	CHEMBL4527	Homo sapiens	IC50	nM	27000.0
	12626654	CHEMBL2319997	Inhibition of TNIK-mediated TCF4/beta-casein transcription in human HCT116 cells by beta-lactamase reporter gene assay	B	COc1cc(Nc2ncc(Cl)c(-c3cccc(CC#N)c3)n2)ccc1N1CCN(C)CC1		CHEMBL2312140	=	IC50	nM	5.4	CHEMBL4527	Homo sapiens	IC50	nM	5.4
	12626656	CHEMBL2317110	Ratio of IC50 for TNIK-mediated TCF4/beta-casein transcription in human HCT116 cells to IC50 for TNIK (unknown origin)	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Ratio IC50		28.0	CHEMBL4527	Homo sapiens	Ratio IC50		28.0
	12626657	CHEMBL2317110	Ratio of IC50 for TNIK-mediated TCF4/beta-casein transcription in human HCT116 cells to IC50 for TNIK (unknown origin)	B	COc1ccc(C#N)cc1-c1ccnc(Nc2ccc(N3CCC(N(C)C)CC3)c(F)c2)c1		CHEMBL2312154	=	Ratio IC50		280.0	CHEMBL4527	Homo sapiens	Ratio IC50		280.0
	12626658	CHEMBL2317110	Ratio of IC50 for TNIK-mediated TCF4/beta-casein transcription in human HCT116 cells to IC50 for TNIK (unknown origin)	B	COc1ccc(C#N)cc1-c1ccnc(Nc2ccc(N3CCOCC3)c(OC)c2)c1		CHEMBL2312148	=	Ratio IC50		790.0	CHEMBL4527	Homo sapiens	Ratio IC50		790.0
	12626659	CHEMBL2317110	Ratio of IC50 for TNIK-mediated TCF4/beta-casein transcription in human HCT116 cells to IC50 for TNIK (unknown origin)	B	COc1ccc(C#N)cc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)c1		CHEMBL2312147	=	Ratio IC50		2400.0	CHEMBL4527	Homo sapiens	Ratio IC50		2400.0
	12626660	CHEMBL2317110	Ratio of IC50 for TNIK-mediated TCF4/beta-casein transcription in human HCT116 cells to IC50 for TNIK (unknown origin)	B	COc1ccc(Cl)cc1-c1ccnc(Nc2ccc(N3CCN(C)CC3)c(OC)c2)c1		CHEMBL2312145	=	Ratio IC50		2000.0	CHEMBL4527	Homo sapiens	Ratio IC50		2000.0
	12626661	CHEMBL2317110	Ratio of IC50 for TNIK-mediated TCF4/beta-casein transcription in human HCT116 cells to IC50 for TNIK (unknown origin)	B	COc1ccc(C#N)cc1-c1ccnc(Nc2ccc(N3CCN(C)CC3)cc2)c1		CHEMBL2312143	>	Ratio IC50		6000.0	CHEMBL4527	Homo sapiens	Ratio IC50		6000.0
	12626662	CHEMBL2317110	Ratio of IC50 for TNIK-mediated TCF4/beta-casein transcription in human HCT116 cells to IC50 for TNIK (unknown origin)	B	COc1cc(Nc2cc(-c3cccc(C#N)c3)ccn2)ccc1N1CCN(C)CC1		CHEMBL2312142	=	Ratio IC50		4500.0	CHEMBL4527	Homo sapiens	Ratio IC50		4500.0
	12626663	CHEMBL2317110	Ratio of IC50 for TNIK-mediated TCF4/beta-casein transcription in human HCT116 cells to IC50 for TNIK (unknown origin)	B	COc1cc(Nc2ncc(Cl)c(-c3cccc(CC#N)c3)n2)ccc1N1CCN(C)CC1		CHEMBL2312140	=	Ratio IC50		5.4	CHEMBL4527	Homo sapiens	Ratio IC50		5.4
	12626719	CHEMBL2316992	Inhibition of TNIK (unknown origin) at 1 uM	B	COc1cc(Nc2cc(-c3cccc(C#N)c3)ccn2)ccc1N1CCN(C)CC1		CHEMBL2312142	>	Inhibition	%	95.0	CHEMBL4527	Homo sapiens	INH	%	95.0
	12626753	CHEMBL2319995	Competitive binding affinity to TNIK (unknown origin) in presence of ATP	B	COc1cc(Nc2cc(-c3cccc(CC#N)c3)ccn2)ccc1N1CCN(C)CC1		CHEMBL2312141	=	Kd	nM	220.0	CHEMBL4527	Homo sapiens	Kd	nM	220.0
	12626754	CHEMBL2319995	Competitive binding affinity to TNIK (unknown origin) in presence of ATP	B	COc1cc(Nc2ncc(Cl)c(-c3cccc(CC#N)c3)n2)ccc1N1CCN(C)CC1		CHEMBL2312140	=	Kd	nM	86.0	CHEMBL4527	Homo sapiens	Kd	nM	86.0
	12626755	CHEMBL2320000	Inhibition of TNIK (unknown origin) by ADP glo luminescent assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	1.4	CHEMBL4527	Homo sapiens	IC50	nM	1.4
	12626756	CHEMBL2320000	Inhibition of TNIK (unknown origin) by ADP glo luminescent assay	B	COc1ccc(Cl)cc1-c1ccnc(Nc2ccc(CCN3CCOCC3)cc2)c1		CHEMBL2312155	=	IC50	nM	20.0	CHEMBL4527	Homo sapiens	IC50	nM	20.0
	12626757	CHEMBL2320000	Inhibition of TNIK (unknown origin) by ADP glo luminescent assay	B	COc1ccc(C#N)cc1-c1ccnc(Nc2ccc(N3CCC(N(C)C)CC3)c(F)c2)c1		CHEMBL2312154	=	IC50	nM	11.0	CHEMBL4527	Homo sapiens	IC50	nM	11.0
	12626758	CHEMBL2320000	Inhibition of TNIK (unknown origin) by ADP glo luminescent assay	B	COc1cc(C#N)cc(-c2ccnc(Nc3ccc(N4CCOCC4)c(OC)c3)c2)c1		CHEMBL2312153	=	IC50	nM	63.0	CHEMBL4527	Homo sapiens	IC50	nM	63.0
	12626759	CHEMBL2320000	Inhibition of TNIK (unknown origin) by ADP glo luminescent assay	B	COc1ccc(C(F)(F)F)cc1-c1ccnc(Nc2ccc(N3CCOCC3)c(OC)c2)c1		CHEMBL2312152	=	IC50	nM	275.0	CHEMBL4527	Homo sapiens	IC50	nM	275.0
	12626760	CHEMBL2320000	Inhibition of TNIK (unknown origin) by ADP glo luminescent assay	B	COc1ccc(F)cc1-c1ccnc(Nc2ccc(N3CCOCC3)c(OC)c2)c1		CHEMBL2312151	=	IC50	nM	118.0	CHEMBL4527	Homo sapiens	IC50	nM	118.0
	12626761	CHEMBL2320000	Inhibition of TNIK (unknown origin) by ADP glo luminescent assay	B	COc1ccc(Cl)cc1-c1ccnc(Nc2ccc(N3CCOCC3)c(OC)c2)c1		CHEMBL2312150	=	IC50	nM	41.0	CHEMBL4527	Homo sapiens	IC50	nM	41.0
	12626762	CHEMBL2320000	Inhibition of TNIK (unknown origin) by ADP glo luminescent assay	B	COc1cc(Nc2cc(-c3ccc(C#N)cc3)ccn2)ccc1N1CCOCC1		CHEMBL2312149	>	IC50	nM	1000.0	CHEMBL4527	Homo sapiens	IC50	nM	1000.0
	12626763	CHEMBL2320000	Inhibition of TNIK (unknown origin) by ADP glo luminescent assay	B	COc1ccc(C#N)cc1-c1ccnc(Nc2ccc(N3CCOCC3)c(OC)c2)c1		CHEMBL2312148	=	IC50	nM	8.0	CHEMBL4527	Homo sapiens	IC50	nM	8.0
	12626764	CHEMBL2320000	Inhibition of TNIK (unknown origin) by ADP glo luminescent assay	B	COc1ccc(C#N)cc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)c1		CHEMBL2312147	=	IC50	nM	11.0	CHEMBL4527	Homo sapiens	IC50	nM	11.0
	12626765	CHEMBL2320000	Inhibition of TNIK (unknown origin) by ADP glo luminescent assay	B	COc1cc(Nc2cc(-c3cccc(C#N)c3)ccn2)ccc1N1CCOCC1		CHEMBL2312146	=	IC50	nM	55.0	CHEMBL4527	Homo sapiens	IC50	nM	55.0
	12626766	CHEMBL2320000	Inhibition of TNIK (unknown origin) by ADP glo luminescent assay	B	COc1ccc(Cl)cc1-c1ccnc(Nc2ccc(N3CCN(C)CC3)c(OC)c2)c1		CHEMBL2312145	=	IC50	nM	4.0	CHEMBL4527	Homo sapiens	IC50	nM	4.0
	12626767	CHEMBL2320000	Inhibition of TNIK (unknown origin) by ADP glo luminescent assay	B	COc1ccc(C#N)cc1-c1ccnc(Nc2ccc(N3CCN(C)CC3)c(OC)c2)c1		CHEMBL2312144	=	IC50	nM	3.0	CHEMBL4527	Homo sapiens	IC50	nM	3.0
	12626768	CHEMBL2320000	Inhibition of TNIK (unknown origin) by ADP glo luminescent assay	B	COc1ccc(C#N)cc1-c1ccnc(Nc2ccc(N3CCN(C)CC3)cc2)c1		CHEMBL2312143	=	IC50	nM	5.0	CHEMBL4527	Homo sapiens	IC50	nM	5.0
	12626769	CHEMBL2320000	Inhibition of TNIK (unknown origin) by ADP glo luminescent assay	B	COc1cc(Nc2cc(-c3cccc(C#N)c3)ccn2)ccc1N1CCN(C)CC1		CHEMBL2312142	=	IC50	nM	6.0	CHEMBL4527	Homo sapiens	IC50	nM	6.0
	12626770	CHEMBL2320000	Inhibition of TNIK (unknown origin) by ADP glo luminescent assay	B	COc1cc(Nc2cc(-c3cccc(CC#N)c3)ccn2)ccc1N1CCN(C)CC1		CHEMBL2312141	=	IC50	nM	290.0	CHEMBL4527	Homo sapiens	IC50	nM	290.0
	12626771	CHEMBL2320000	Inhibition of TNIK (unknown origin) by ADP glo luminescent assay	B	COc1cc(Nc2ncc(Cl)c(-c3cccc(CC#N)c3)n2)ccc1N1CCN(C)CC1		CHEMBL2312140	=	IC50	nM	65.0	CHEMBL4527	Homo sapiens	IC50	nM	65.0
	13439920	CHEMBL2429298	Competitive binding affinity to TNIK (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL4527	Homo sapiens	INH	%	50.0
	13445426	CHEMBL2429298	Competitive binding affinity to TNIK (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	=	Inhibition	%	99.0	CHEMBL4527	Homo sapiens	INH	%	99.0
	13448485	CHEMBL2429298	Competitive binding affinity to TNIK (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	=	Inhibition	%	79.0	CHEMBL4527	Homo sapiens	INH	%	79.0
	13448615	CHEMBL2429298	Competitive binding affinity to TNIK (unknown origin) at 10 uM in presence of ATP relative to control	B	O=C([C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1)N1CCOCC1		CHEMBL2425649	<	Inhibition	%	50.0	CHEMBL4527	Homo sapiens	INH	%	50.0
	13451410	CHEMBL2429298	Competitive binding affinity to TNIK (unknown origin) at 10 uM in presence of ATP relative to control	B	N[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425652	=	Inhibition	%	92.0	CHEMBL4527	Homo sapiens	INH	%	92.0
	13454601	CHEMBL2429298	Competitive binding affinity to TNIK (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL4527	Homo sapiens	INH	%	50.0
Active	13475271	CHEMBL2438985	Binding affinity to human wild type TNIK at 1 uM by qPCR analysis	B	CCSCc1ccc2c(c1)c1c3c(c4c5cc(CSCC)ccc5n5c4c1n2[C@H]1C[C@](O)(C(=O)OC)[C@]5(C)O1)CNC3=O		CHEMBL290352		Inhibition	%		CHEMBL4527	Homo sapiens	INH		
Active	13475272	CHEMBL2438985	Binding affinity to human wild type TNIK at 1 uM by qPCR analysis	B	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5ccc6[nH]ccc6c5)c4c3)cc2)CC1		CHEMBL2436978		Inhibition	%		CHEMBL4527	Homo sapiens	INH		
Not Active	13907185	CHEMBL3118661	Inhibition of TNIK (unknown origin) at 10 uM	B	CCCCCCCCCC(NC(=O)CNC(=O)OCc1ccccc1)C(=O)NCCc1ccccc1		CHEMBL3113587		Inhibition	%		CHEMBL4527	Homo sapiens	INH		
	15150163	CHEMBL3396187	Inhibition of TNIK (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CC2)ccn1		CHEMBL3394102	<	Inhibition	%	50.0	CHEMBL4527	Homo sapiens	INH	%	50.0
	15150164	CHEMBL3396187	Inhibition of TNIK (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CCCCC2)ccn1		CHEMBL3394105	<	Inhibition	%	50.0	CHEMBL4527	Homo sapiens	INH	%	50.0
	15150165	CHEMBL3396187	Inhibition of TNIK (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2CC2CCCO2)ccn1		CHEMBL3394108	<	Inhibition	%	50.0	CHEMBL4527	Homo sapiens	INH	%	50.0
	15150166	CHEMBL3396187	Inhibition of TNIK (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	COC(Cn1c(SC2CCC(C(=O)O)CC2O)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(C)=O)c1)OC		CHEMBL3394112	<	Inhibition	%	50.0	CHEMBL4527	Homo sapiens	INH	%	50.0
	15150167	CHEMBL3396187	Inhibition of TNIK (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(Sc3cccc(I)n3)n2C2CCCCC2)ccn1		CHEMBL3394118	<	Inhibition	%	50.0	CHEMBL4527	Homo sapiens	INH	%	50.0
	15258384	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Thermal melting change	degrees C	8.3	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	8.3
	15258444	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Thermal melting change	degrees C	-0.2	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	-0.2
	15258504	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Thermal melting change	degrees C	0.1	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.1
	15258564	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Thermal melting change	degrees C	-1.0	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	-1.0
	15258624	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Thermal melting change	degrees C	-0.4	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	-0.4
	15258684	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Thermal melting change	degrees C	-1.6	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	-1.6
	15258744	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Thermal melting change	degrees C	-0.7	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	-0.7
	15258804	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	O=C(O)Cc1ccc(O)c([N+](=O)[O-])c1		CHEMBL501822	=	Thermal melting change	degrees C	-0.2	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	-0.2
	15258864	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL319467	=	Thermal melting change	degrees C	-0.3	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	-0.3
	15258924	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Thermal melting change	degrees C	0.0	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.0
	15258984	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	CS(=O)(=O)O.Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL1642	=	Thermal melting change	degrees C	0.0	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.0
	15259044	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Thermal melting change	degrees C	3.4	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	3.4
	15259104	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Thermal melting change	degrees C	5.4	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	5.4
	15259164	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL216543	=	Thermal melting change	degrees C	5.9	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	5.9
	15259224	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Thermal melting change	degrees C	9.9	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	9.9
	15259284	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	Cn1cc(/C=C2/C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL3430785	=	Thermal melting change	degrees C	1.3	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	1.3
	15259344	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B			CHEMBL3430786	=	Thermal melting change	degrees C	-2.3	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	-2.3
	15259404	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	CCOc1ccc(/C=C2/SC(=O)N(CCN)C2=O)cc1		CHEMBL262615	=	Thermal melting change	degrees C	-0.4	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	-0.4
	15259464	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	O=c1c(-c2ccc(F)cc2)c(-c2ccncc2)[nH]n1-c1ccc(Cl)cc1		CHEMBL408678	=	Thermal melting change	degrees C	-0.2	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	-0.2
	15259524	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Thermal melting change	degrees C	-1.2	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	-1.2
	15259584	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Thermal melting change	degrees C	-0.9	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	-0.9
	15259644	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2[C@H]2CC[C@H](O)CC2)n1		CHEMBL97162	=	Thermal melting change	degrees C	-0.5	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	-0.5
	15259704	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Thermal melting change	degrees C	-0.3	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	-0.3
	15259764	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Thermal melting change	degrees C	0.7	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.7
	15259824	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	CCCNC(=O)Nc1ccc(Oc2ncnc3cc(OC)c(OC)cc23)cc1Cl		CHEMBL406381	=	Thermal melting change	degrees C	0.2	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.2
	15259884	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Thermal melting change	degrees C	0.9	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.9
	15259944	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Thermal melting change	degrees C	0.1	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.1
	15260004	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	Cl.NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL558969	=	Thermal melting change	degrees C	1.3	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	1.3
	15260064	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)c(C)c1C(=O)N1CCN(C)CC1		CHEMBL261641	=	Thermal melting change	degrees C	0.4	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.4
	15260124	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Thermal melting change	degrees C	1.1	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	1.1
	15260184	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Thermal melting change	degrees C	0.7	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.7
	15260244	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B			CHEMBL3430787	=	Thermal melting change	degrees C	-0.5	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	-0.5
	15260304	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Thermal melting change	degrees C	-0.2	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	-0.2
	15260364	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	CN(c1cccnc1)c1cc2c(Nc3ccc(F)c(Cl)c3)c(C#N)cnc2cn1		CHEMBL261238	=	Thermal melting change	degrees C	-1.2	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	-1.2
	15260424	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Thermal melting change	degrees C	0.0	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.0
	15260484	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Thermal melting change	degrees C	-1.4	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	-1.4
	15260544	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	Cc1nc(N)sc1-c1ccnc(Nc2cccc([N+](=O)[O-])c2)n1		CHEMBL298445	=	Thermal melting change	degrees C	0.9	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.9
	15260604	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Thermal melting change	degrees C	0.2	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.2
Not Determined	15260664	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B			CHEMBL3430788		Thermal melting change			CHEMBL4527	Homo sapiens	Thermal melting change		
Not Determined	15260724	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721		Thermal melting change			CHEMBL4527	Homo sapiens	Thermal melting change		
Not Determined	15260784	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259		Thermal melting change			CHEMBL4527	Homo sapiens	Thermal melting change		
Not Determined	15260844	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	CN1CCc2[nH]c(=S)c(C#N)c(-c3cccs3)c2C1		CHEMBL261211		Thermal melting change			CHEMBL4527	Homo sapiens	Thermal melting change		
Not Determined	15260904	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(O)c1c(F)cccc1F		CHEMBL259605		Thermal melting change			CHEMBL4527	Homo sapiens	Thermal melting change		
Not Determined	15260964	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421		Thermal melting change			CHEMBL4527	Homo sapiens	Thermal melting change		
Not Determined	15261024	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253		Thermal melting change			CHEMBL4527	Homo sapiens	Thermal melting change		
Not Determined	15261084	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	CN1CCC(Nc2ncc3ncnc(Nc4ccc(F)c(Cl)c4)c3n2)CC1		CHEMBL258940		Thermal melting change			CHEMBL4527	Homo sapiens	Thermal melting change		
	15261144	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Thermal melting change	degrees C	-1.0	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	-1.0
	15261167	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Thermal melting change	degrees C	2.0	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	2.0
	15261227	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Thermal melting change	degrees C	4.6	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	4.6
	15261287	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	Brc1c(Br)c(Br)c2[nH]nnc2c1Br		CHEMBL177820	=	Thermal melting change	degrees C	-0.8	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	-0.8
	15261347	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	Nc1cc2ncnc(Nc3cccc(Br)c3)c2cc1N		CHEMBL328216	=	Thermal melting change	degrees C	0.5	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.5
	15261402	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Thermal melting change	degrees C	-0.6	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	-0.6
	15261462	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	NC1=N/C(=C2/CCNC(=O)c3[nH]ccc32)C(=O)N1		CHEMBL255465	=	Thermal melting change	degrees C	1.6	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	1.6
	15261522	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	COc1cc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc(OC)c(OC)c2)ccc1O		CHEMBL435734	=	Thermal melting change	degrees C	-0.2	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	-0.2
	15261582	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	O=C1C=C2C(=Nc3c2c2c(c4c3=NC3=C4CCC=C3)C=NC=2)CC1		CHEMBL408953	=	Thermal melting change	degrees C	1.3	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	1.3
	15261642	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC.[Cl-]		CHEMBL258893	=	Thermal melting change	degrees C	-1.3	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	-1.3
	15261655	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Thermal melting change	degrees C	3.1	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	3.1
	15261715	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OC		CHEMBL29197	=	Thermal melting change	degrees C	2.0	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	2.0
	15261775	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	C[S+]([O-])c1ccc(CSc2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL111456	=	Thermal melting change	degrees C	0.1	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.1
	15261835	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12		CHEMBL28	=	Thermal melting change	degrees C	5.3	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	5.3
	15261951	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Thermal melting change	degrees C	-0.2	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	-0.2
	15262011	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	CC(C)c1cc(/C=C(\C#N)C(=O)NCCCc2ccccc2)cc(C(C)C)c1O		CHEMBL261508	=	Thermal melting change	degrees C	0.0	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.0
	15262071	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Thermal melting change	degrees C	0.6	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.6
	15262131	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B			CHEMBL3430782	=	Thermal melting change	degrees C	2.7	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	2.7
	15262144	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12		CHEMBL44	=	Thermal melting change	degrees C	0.4	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.4
	15262204	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Thermal melting change	degrees C	4.5	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	4.5
	15262264	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Thermal melting change	degrees C	1.4	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	1.4
	15262324	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	Nc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL99203	=	Thermal melting change	degrees C	1.6	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	1.6
	15262384	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	O=C(O)c1cc(NCc2cc(O)ccc2O)ccc1O		CHEMBL319620	=	Thermal melting change	degrees C	0.0	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.0
	15262444	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	OC[C@H]1O[C@@H](n2cnc3cc(Cl)c(Cl)cc32)[C@H](O)[C@@H]1O		CHEMBL375530	=	Thermal melting change	degrees C	0.2	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.2
	15262504	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	O=C(O)c1cc(N(Cc2ccccc2O)Cc2cc(O)ccc2O)ccc1O		CHEMBL103552	=	Thermal melting change	degrees C	0.0	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.0
	15262564	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	O=C1Nc2ccc(I)cc2/C1=C\c1cc(Br)c(O)c(Br)c1		CHEMBL264949	=	Thermal melting change	degrees C	3.9	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	3.9
	15262624	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Thermal melting change	degrees C	0.4	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.4
	15262684	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	CN(C)c1ncnc2nc[nH]c12		CHEMBL407391	=	Thermal melting change	degrees C	0.0	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.0
	15262744	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	Cc1ccc2c(c1)C(=O)c1cc(O)cc(O)c1C2=O		CHEMBL405992	=	Thermal melting change	degrees C	0.7	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.7
	15262804	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	O=c1ccc2ccc(O)c(O)c2o1		CHEMBL244948	=	Thermal melting change	degrees C	0.3	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.3
	15262864	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	COc1cc(O)c2c(c1)oc(=O)c1c3cc(O)c(O)cc3oc21		CHEMBL97453	=	Thermal melting change	degrees C	1.3	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	1.3
	15262924	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Thermal melting change	degrees C	0.0	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.0
	15262984	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Thermal melting change	degrees C	7.6	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	7.6
	15263044	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Thermal melting change	degrees C	6.7	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	6.7
	15263104	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Thermal melting change	degrees C	6.1	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	6.1
	15263164	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	N#CC(C#N)=Cc1ccc(O)c(O)c1		CHEMBL76904	=	Thermal melting change	degrees C	0.2	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.2
	15263224	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Thermal melting change	degrees C	0.8	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.8
	15263284	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)Nc1ccccc1		CHEMBL56731	=	Thermal melting change	degrees C	1.0	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	1.0
	15263344	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	CCOc1cc(/C=C(\C#N)C(N)=O)cc(CSc2ccccc2)c1O		CHEMBL485070	=	Thermal melting change	degrees C	0.2	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.2
	15263440	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Thermal melting change	degrees C	1.6	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	1.6
	15263495	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	C/C(O)=C(\C#N)C(=O)Nc1cc(Br)ccc1Br		CHEMBL228043	=	Thermal melting change	degrees C	-0.1	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	-0.1
	15263555	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	O=C1c2ccccc2-c2n[nH]c3cccc1c23		CHEMBL7064	=	Thermal melting change	degrees C	3.0	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	3.0
	15263615	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B			CHEMBL3430783	=	Thermal melting change	degrees C	6.6	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	6.6
	15263675	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	Cc1nc2sccn2c(=O)c1CCN1CCC(=C(c2ccccc2)c2ccc(F)cc2)CC1		CHEMBL259388	=	Thermal melting change	degrees C	2.9	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	2.9
	15263749	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Thermal melting change	degrees C	0.1	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.1
	15263809	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12		CHEMBL406821	=	Thermal melting change	degrees C	1.0	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	1.0
	15263869	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Thermal melting change	degrees C	0.4	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.4
	15263929	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	CN(C)c1ccc(CC2C(=O)Nc3ccccc32)cc1		CHEMBL1373282	=	Thermal melting change	degrees C	4.1	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	4.1
	15263983	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	Cc1c2ccncc2c(C)c2c1[nH]c1ccccc12		CHEMBL123	=	Thermal melting change	degrees C	-0.2	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	-0.2
	15264043	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	CCOC(=O)c1cnc2oc3ccc(O)cc3c2c1-c1ccccc1		CHEMBL132904	=	Thermal melting change	degrees C	1.3	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	1.3
	15264103	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21.[Cl-]		CHEMBL258765	=	Thermal melting change	degrees C	-0.9	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	-0.9
	15264163	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	COC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O		CHEMBL278315	=	Thermal melting change	degrees C	-0.4	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	-0.4
	15264236	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	O=C1Nc2ccccc2/C1=C/c1cc2c([nH]1)CCC(Br)C2		CHEMBL408565	=	Thermal melting change	degrees C	5.9	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	5.9
	15264296	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	O=C1Nc2ccccc2/C1=C/c1cnc[nH]1		CHEMBL261692	=	Thermal melting change	degrees C	6.1	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	6.1
	15264356	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	O=S(=O)(c1cccc2c(Cl)cccc12)N1CCCNCC1		CHEMBL429298	=	Thermal melting change	degrees C	0.1	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.1
	15264416	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O		CHEMBL116438	=	Thermal melting change	degrees C	5.9	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	5.9
	15264472	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Thermal melting change	degrees C	-0.1	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	-0.1
	15264532	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Thermal melting change	degrees C	5.9	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	5.9
	15264592	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	COC(=O)[C@]1(O)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL416056	=	Thermal melting change	degrees C	8.7	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	8.7
	15264652	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Thermal melting change	degrees C	1.3	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	1.3
	15264712	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	Cl.NCCNS(=O)(=O)c1cccc2c(Cl)cccc12		CHEMBL1255867	=	Thermal melting change	degrees C	0.0	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.0
	15264724	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	NC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c(Br)cc32)N1		CHEMBL361708	=	Thermal melting change	degrees C	4.7	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	4.7
	15264784	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	Cc1cc(C=C2C(=O)C=CC2=O)cc(C)c1O		CHEMBL437612	=	Thermal melting change	degrees C	-4.1	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	-4.1
	15264844	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	CC(C)(C)c1cc(C=C2C(=O)C=CC2=O)cc(C(C)(C)C)c1O		CHEMBL258726	=	Thermal melting change	degrees C	-3.1	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	-3.1
	15264904	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Thermal melting change	degrees C	3.0	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	3.0
	15264964	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	CC(C)N(CCO)c1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL126254	=	Thermal melting change	degrees C	3.6	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	3.6
	15265020	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	N=C(N)NCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL143054	=	Thermal melting change	degrees C	0.1	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.1
	15265080	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	CNC(=O)c1cc(Oc2ccc(Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL3430784	=	Thermal melting change	degrees C	0.0	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.0
	15265140	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Thermal melting change	degrees C	0.3	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.3
	15265200	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	CCn1cnc2c(N)nc(N(c3cccc(Cl)c3)[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL411901	=	Thermal melting change	degrees C	2.3	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	2.3
	15265273	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Thermal melting change	degrees C	3.1	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	3.1
	15265333	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc21		CHEMBL280074	=	Thermal melting change	degrees C	0.3	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.3
	15265393	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	CC(C)n1cnc2c(NCc3ccccc3O)nc(NCCCO)nc21		CHEMBL419931	=	Thermal melting change	degrees C	0.0	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.0
	15265453	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Thermal melting change	degrees C	0.5	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.5
	15265509	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Thermal melting change	degrees C	0.0	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.0
	15265569	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	Thermal melting change	degrees C	0.1	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.1
	15265629	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Thermal melting change	degrees C	0.3	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.3
	15265689	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	C[C@@H]1C[C@H]2O[C@@H]2/C=C\C=C\C(=O)Cc2c(Cl)c(O)cc(O)c2C(=O)O1		CHEMBL414883	=	Thermal melting change	degrees C	-0.3	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	-0.3
	15265761	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Thermal melting change	degrees C	0.3	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.3
	15265821	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Thermal melting change	degrees C	0.4	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.4
	15265881	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	O=C(O)/C=C/c1cc(CO)ccc1CO		CHEMBL407534	=	Thermal melting change	degrees C	0.8	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.8
	15265941	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Thermal melting change	degrees C	-0.1	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	-0.1
	15265998	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Thermal melting change	degrees C	4.2	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	4.2
	15266058	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	Oc1cc(O)cc(/C=C/c2ccc(O)c(O)c2)c1		CHEMBL69863	=	Thermal melting change	degrees C	0.4	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.4
	15266118	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	N#C/C(=C(/N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL261237	=	Thermal melting change	degrees C	-0.1	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	-0.1
	15266178	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	O=C1Nc2ccc(I)cc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL411645	=	Thermal melting change	degrees C	5.2	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	5.2
	15266250	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	O=C1CC(=O)c2[nH]c3c4[nH]c5c(c4c4cn(Br)cc4c3c2C1)CCC=C5		CHEMBL264685	=	Thermal melting change	degrees C	3.9	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	3.9
	15266310	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Thermal melting change	degrees C	-2.4	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	-2.4
	15266370	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Thermal melting change	degrees C	-0.3	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	-0.3
	15266430	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	O=C1Nc2ccccc2/C1=C\c1ccc[nH]1		CHEMBL101797	=	Thermal melting change	degrees C	6.2	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	6.2
	15266485	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	O=C1Nc2ccc(S(=O)(=O)O)cc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL440411	=	Thermal melting change	degrees C	2.4	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	2.4
	15266545	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	CC(=O)O/N=C1C(=C2/C(=O)Nc3cc(Br)ccc32)/Nc2ccccc2/1		CHEMBL430226	=	Thermal melting change	degrees C	0.4	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.4
	15266605	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Thermal melting change	degrees C	2.0	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	2.0
	15266665	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	CC(=O)O.Cn1cc(C2=C(c3cn(CCCN)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL3430781	=	Thermal melting change	degrees C	0.8	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.8
	15266738	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12		CHEMBL50	=	Thermal melting change	degrees C	3.3	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	3.3
	15266798	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Thermal melting change	degrees C	0.8	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.8
	15266858	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Thermal melting change	degrees C	5.7	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	5.7
	15266918	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Thermal melting change	degrees C	0.0	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.0
	15266973	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Thermal melting change	degrees C	1.2	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	1.2
	15267033	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	CS(=O)(=O)O.Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL1591531	=	Thermal melting change	degrees C	3.8	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	3.8
	15267093	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	Cl.Cn1cc(C2=C(c3ccc4cc5n(c4c3)CCC(CN)C5)C(=O)NC2=O)c2ccccc21		CHEMBL541401	=	Thermal melting change	degrees C	0.3	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.3
	15267153	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	CN(C)CC1CCn2c(c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc32)C1		CHEMBL372585	=	Thermal melting change	degrees C	0.5	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.5
	15267226	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Thermal melting change	degrees C	0.7	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.7
	15267286	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Thermal melting change	degrees C	0.4	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.4
	15267346	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	COc1cc2ncnc(Nc3cccc(O)c3)c2cc1OC		CHEMBL127907	=	Thermal melting change	degrees C	0.9	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.9
	15267406	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Thermal melting change	degrees C	1.9	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	1.9
	15267461	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	CN[C@@H]1CC2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL162	=	Thermal melting change	degrees C	9.4	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	9.4
	15267521	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	O=c1sn(Cc2ccccc2)c(=S)n1Cc1ccccc1		CHEMBL24338	=	Thermal melting change	degrees C	0.0	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.0
	15267581	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	C=CNC#N		CHEMBL259526	=	Thermal melting change	degrees C	0.1	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	0.1
	15267641	CHEMBL3430843	Delta TM value showing the stabilisation of TNIK produced by compound binding	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(/N)Sc1ccccc1N		CHEMBL100473	=	Thermal melting change	degrees C	-0.3	CHEMBL4527	Homo sapiens	Thermal melting change	degrees C	-0.3
	15756786	CHEMBL3631500	Inhibition of TNIK (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	93.86	CHEMBL4527	Homo sapiens	INH	%	93.86
	15757937	CHEMBL3631500	Inhibition of TNIK (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	82.58	CHEMBL4527	Homo sapiens	INH	%	82.58
	15758916	CHEMBL3631500	Inhibition of TNIK (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	48.39	CHEMBL4527	Homo sapiens	INH	%	48.39
	16432032	CHEMBL3750186	Inhibition of human TNIK using [RLGRDKYKTLRQIRQ] as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	5000.0	CHEMBL4527	Homo sapiens	IC50	uM	5.0
Not Determined	16433766	CHEMBL3756566	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate after 1 hr in presence of 30 uM ATP	B	O=C(NNC(=O)c1cc2ccccc2cc1O)NC1CCCCC1		CHEMBL1418792		IC50			CHEMBL4527	Homo sapiens	IC50		
Not Determined	16433767	CHEMBL3756566	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate after 1 hr in presence of 30 uM ATP	B	CN1CCN(c2ccc(NC(=O)c3cccc(Cl)c3)cc2)CC1		CHEMBL3752887		IC50			CHEMBL4527	Homo sapiens	IC50		
Not Determined	16433768	CHEMBL3756566	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate after 1 hr in presence of 30 uM ATP	B	CN(C)c1ccc(NC(=O)c2cc3ccccc3o2)cc1		CHEMBL2315760		IC50			CHEMBL4527	Homo sapiens	IC50		
Not Determined	16433769	CHEMBL3756566	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate after 1 hr in presence of 30 uM ATP	B	Cc1ccc(-c2cc(C(=O)Nc3ccncc3)no2)cc1		CHEMBL3752773		IC50			CHEMBL4527	Homo sapiens	IC50		
Not Determined	16433770	CHEMBL3756566	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate after 1 hr in presence of 30 uM ATP	B	Cc1ccc(NC=C2C(=O)c3ccccc3C2=O)cc1C		CHEMBL3752723		IC50			CHEMBL4527	Homo sapiens	IC50		
	16433771	CHEMBL3756566	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate after 1 hr in presence of 30 uM ATP	B	O=C(Nc1ccc(Br)cc1)Nc1ccc(CN2CCCC2)cc1		CHEMBL3752961	=	IC50	nM	3510.0	CHEMBL4527	Homo sapiens	IC50	uM	3.51
	16433772	CHEMBL3756566	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate after 1 hr in presence of 30 uM ATP	B	CC(C)(C)c1ccc(/C=C/C(=O)Nc2ccccc2C(N)=O)cc1		CHEMBL3753203	=	IC50	nM	2740.0	CHEMBL4527	Homo sapiens	IC50	uM	2.74
	16433773	CHEMBL3756566	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate after 1 hr in presence of 30 uM ATP	B	CN1CCN(c2ccc(NC(=O)c3ccc(-c4cc(Cl)ccc4Cl)o3)cc2)CC1		CHEMBL3754324	=	IC50	nM	850.0	CHEMBL4527	Homo sapiens	IC50	uM	0.85
	16433774	CHEMBL3756566	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate after 1 hr in presence of 30 uM ATP	B	CC[C@@H]1CCc2c(sc(NC(=O)Nc3ccccc3)c2C(N)=O)C1		CHEMBL3751990	=	IC50	nM	10310.0	CHEMBL4527	Homo sapiens	IC50	uM	10.31
	16433775	CHEMBL3756566	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate after 1 hr in presence of 30 uM ATP	B	O=C(Nc1nnc(/C=C/c2ccccc2)s1)c1ccco1		CHEMBL1379988	=	IC50	nM	3570.0	CHEMBL4527	Homo sapiens	IC50	uM	3.57
	16433776	CHEMBL3756565	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate at 10 uM after 1 hr in presence of 30 uM ATP	B	Cc1cc(C(=O)Nc2cccc(S(=O)(=O)N3CCOCC3)c2)sc1-c1ccccc1		CHEMBL3753236	=	Inhibition	%	-4.9	CHEMBL4527	Homo sapiens	INH	%	-4.9
	16433777	CHEMBL3756565	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate at 10 uM after 1 hr in presence of 30 uM ATP	B	CC(C)C(=O)Nc1cccc(NC(=O)c2ccc(-c3ccc(Cl)cc3)o2)c1		CHEMBL3752542	=	Inhibition	%	4.1	CHEMBL4527	Homo sapiens	INH	%	4.1
	16433778	CHEMBL3756565	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate at 10 uM after 1 hr in presence of 30 uM ATP	B	Cc1cc([N+](=O)[O-])ccc1NC(=O)c1ccc(-c2cccc(Cl)c2Cl)o1		CHEMBL3753859	=	Inhibition	%	4.9	CHEMBL4527	Homo sapiens	INH	%	4.9
	16433779	CHEMBL3756565	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate at 10 uM after 1 hr in presence of 30 uM ATP	B	O=C(Nc1cc(Cl)cc(Cl)c1)c1ccc(-c2ccc([N+](=O)[O-])cc2)o1		CHEMBL3752894	=	Inhibition	%	8.9	CHEMBL4527	Homo sapiens	INH	%	8.9
	16433780	CHEMBL3756565	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate at 10 uM after 1 hr in presence of 30 uM ATP	B	Cc1ccccc1C(=O)N1CCN(c2ccc(NC(=O)c3ccc(-c4ccc(Cl)cc4)o3)cc2)CC1		CHEMBL3752215	=	Inhibition	%	12.9	CHEMBL4527	Homo sapiens	INH	%	12.9
	16433781	CHEMBL3756565	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate at 10 uM after 1 hr in presence of 30 uM ATP	B	O=C(Nc1cccc(NC(=O)c2ccc(Cl)cc2Cl)c1)c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL3754520	=	Inhibition	%	16.8	CHEMBL4527	Homo sapiens	INH	%	16.8
	16433782	CHEMBL3756565	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate at 10 uM after 1 hr in presence of 30 uM ATP	B	O=C(Nc1cccc(Cl)c1N1CCCCC1)c1ccc(-c2ccc(F)cc2)o1		CHEMBL3754752	=	Inhibition	%	19.9	CHEMBL4527	Homo sapiens	INH	%	19.9
	16433783	CHEMBL3756565	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate at 10 uM after 1 hr in presence of 30 uM ATP	B	Cc1cc([N+](=O)[O-])ccc1-c1ccc(C(=O)Nc2cccc(Cl)c2N2CCOCC2)o1		CHEMBL3754714	=	Inhibition	%	22.3	CHEMBL4527	Homo sapiens	INH	%	22.3
	16433784	CHEMBL3756565	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate at 10 uM after 1 hr in presence of 30 uM ATP	B	O=C(Nc1ccccc1Cl)c1ccc(-c2ccc(Cl)cc2)o1		CHEMBL3753900	=	Inhibition	%	18.7	CHEMBL4527	Homo sapiens	INH	%	18.7
	16433785	CHEMBL3756565	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate at 10 uM after 1 hr in presence of 30 uM ATP	B	CC(=O)Nc1ccc(NC(=O)c2ccc(-c3ccc(Cl)c(Cl)c3)o2)cc1		CHEMBL3751864	=	Inhibition	%	23.1	CHEMBL4527	Homo sapiens	INH	%	23.1
	16433786	CHEMBL3756565	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate at 10 uM after 1 hr in presence of 30 uM ATP	B	Cc1cc(C(=O)Nc2ccc(C(=O)N3CCOCC3)cc2)sc1-c1ccccc1		CHEMBL3752782	=	Inhibition	%	60.4	CHEMBL4527	Homo sapiens	INH	%	60.4
	16433787	CHEMBL3756565	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate at 10 uM after 1 hr in presence of 30 uM ATP	B	Cc1cc(C(=O)Nc2ccccc2C(N)=O)sc1-c1ccccc1		CHEMBL3753804	=	Inhibition	%	61.7	CHEMBL4527	Homo sapiens	INH	%	61.7
	16433788	CHEMBL3756565	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate at 10 uM after 1 hr in presence of 30 uM ATP	B	CNS(=O)(=O)c1ccc(NC(=O)c2cc(C)c(-c3ccccc3)s2)cc1		CHEMBL3752715	=	Inhibition	%	72.8	CHEMBL4527	Homo sapiens	INH	%	72.8
	16433789	CHEMBL3756565	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate at 10 uM after 1 hr in presence of 30 uM ATP	B	Cc1c(Cl)cccc1-c1ccc(C(=O)Nc2ccc(S(N)(=O)=O)cc2)o1		CHEMBL3752265	=	Inhibition	%	76.4	CHEMBL4527	Homo sapiens	INH	%	76.4
	16433790	CHEMBL3756565	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate at 10 uM after 1 hr in presence of 30 uM ATP	B	COc1ccc(C(=O)/C=C/Nc2ccc(C)c(C)c2)cc1		CHEMBL3754101	=	Inhibition	%	32.0	CHEMBL4527	Homo sapiens	INH	%	32.0
	16433791	CHEMBL3756565	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate at 10 uM after 1 hr in presence of 30 uM ATP	B	CCC(=O)N1CCN(c2ccc(NC(=O)c3cc4ccccc4o3)cc2)CC1		CHEMBL1364452	=	Inhibition	%	46.0	CHEMBL4527	Homo sapiens	INH	%	46.0
	16433792	CHEMBL3756565	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate at 10 uM after 1 hr in presence of 30 uM ATP	B	O=C(NNC(=O)c1cc2ccccc2cc1O)NC1CCCCC1		CHEMBL1418792	=	Inhibition	%	42.0	CHEMBL4527	Homo sapiens	INH	%	42.0
	16433793	CHEMBL3756565	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate at 10 uM after 1 hr in presence of 30 uM ATP	B	CN1CCN(c2ccc(NC(=O)c3cccc(Cl)c3)cc2)CC1		CHEMBL3752887	=	Inhibition	%	45.0	CHEMBL4527	Homo sapiens	INH	%	45.0
	16433794	CHEMBL3756565	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate at 10 uM after 1 hr in presence of 30 uM ATP	B	CN(C)c1ccc(NC(=O)c2cc3ccccc3o2)cc1		CHEMBL2315760	=	Inhibition	%	39.0	CHEMBL4527	Homo sapiens	INH	%	39.0
	16433795	CHEMBL3756565	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate at 10 uM after 1 hr in presence of 30 uM ATP	B	Cc1ccc(-c2cc(C(=O)Nc3ccncc3)no2)cc1		CHEMBL3752773	=	Inhibition	%	40.0	CHEMBL4527	Homo sapiens	INH	%	40.0
	16433796	CHEMBL3756565	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate at 10 uM after 1 hr in presence of 30 uM ATP	B	Cc1ccc(NC=C2C(=O)c3ccccc3C2=O)cc1C		CHEMBL3752723	=	Inhibition	%	43.0	CHEMBL4527	Homo sapiens	INH	%	43.0
	16433797	CHEMBL3756565	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate at 10 uM after 1 hr in presence of 30 uM ATP	B	O=C(Nc1ccc(Br)cc1)Nc1ccc(CN2CCCC2)cc1		CHEMBL3752961	=	Inhibition	%	72.0	CHEMBL4527	Homo sapiens	INH	%	72.0
	16433798	CHEMBL3756565	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate at 10 uM after 1 hr in presence of 30 uM ATP	B	CC(C)(C)c1ccc(/C=C/C(=O)Nc2ccccc2C(N)=O)cc1		CHEMBL3753203	=	Inhibition	%	63.0	CHEMBL4527	Homo sapiens	INH	%	63.0
	16433799	CHEMBL3756565	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate at 10 uM after 1 hr in presence of 30 uM ATP	B	CN1CCN(c2ccc(NC(=O)c3ccc(-c4cc(Cl)ccc4Cl)o3)cc2)CC1		CHEMBL3754324	=	Inhibition	%	94.0	CHEMBL4527	Homo sapiens	INH	%	94.0
	16433800	CHEMBL3756565	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate at 10 uM after 1 hr in presence of 30 uM ATP	B	CC[C@@H]1CCc2c(sc(NC(=O)Nc3ccccc3)c2C(N)=O)C1		CHEMBL3751990	=	Inhibition	%	79.0	CHEMBL4527	Homo sapiens	INH	%	79.0
	16433801	CHEMBL3756565	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate at 10 uM after 1 hr in presence of 30 uM ATP	B	O=C(Nc1nnc(/C=C/c2ccccc2)s1)c1ccco1		CHEMBL1379988	=	Inhibition	%	70.0	CHEMBL4527	Homo sapiens	INH	%	70.0
	16433802	CHEMBL3756564	Binding affinity to TNIK (unknown origin)	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	25.0	CHEMBL4527	Homo sapiens	Kd	nM	25.0
	16433803	CHEMBL3756564	Binding affinity to TNIK (unknown origin)	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	24.0	CHEMBL4527	Homo sapiens	Kd	nM	24.0
	16433804	CHEMBL3756564	Binding affinity to TNIK (unknown origin)	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	140.0	CHEMBL4527	Homo sapiens	Kd	nM	140.0
Not Determined	16433805	CHEMBL3756566	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate after 1 hr in presence of 30 uM ATP	B	CCC(=O)N1CCN(c2ccc(NC(=O)c3cc4ccccc4o3)cc2)CC1		CHEMBL1364452		IC50			CHEMBL4527	Homo sapiens	IC50		
Not Determined	16433806	CHEMBL3756566	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate after 1 hr in presence of 30 uM ATP	B	COc1ccc(C(=O)/C=C/Nc2ccc(C)c(C)c2)cc1		CHEMBL3754101		IC50			CHEMBL4527	Homo sapiens	IC50		
	16433807	CHEMBL3756566	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate after 1 hr in presence of 30 uM ATP	B	Cc1c(Cl)cccc1-c1ccc(C(=O)Nc2ccc(S(N)(=O)=O)cc2)o1		CHEMBL3752265	=	IC50	nM	260.0	CHEMBL4527	Homo sapiens	IC50	uM	0.26
Not Determined	16433808	CHEMBL3756566	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate after 1 hr in presence of 30 uM ATP	B	CNS(=O)(=O)c1ccc(NC(=O)c2cc(C)c(-c3ccccc3)s2)cc1		CHEMBL3752715		IC50			CHEMBL4527	Homo sapiens	IC50		
Not Determined	16433809	CHEMBL3756566	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate after 1 hr in presence of 30 uM ATP	B	Cc1cc(C(=O)Nc2ccccc2C(N)=O)sc1-c1ccccc1		CHEMBL3753804		IC50			CHEMBL4527	Homo sapiens	IC50		
Not Determined	16433810	CHEMBL3756566	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate after 1 hr in presence of 30 uM ATP	B	Cc1cc(C(=O)Nc2ccc(C(=O)N3CCOCC3)cc2)sc1-c1ccccc1		CHEMBL3752782		IC50			CHEMBL4527	Homo sapiens	IC50		
Not Determined	16433811	CHEMBL3756566	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate after 1 hr in presence of 30 uM ATP	B	CC(=O)Nc1ccc(NC(=O)c2ccc(-c3ccc(Cl)c(Cl)c3)o2)cc1		CHEMBL3751864		IC50			CHEMBL4527	Homo sapiens	IC50		
Not Determined	16433812	CHEMBL3756566	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate after 1 hr in presence of 30 uM ATP	B	O=C(Nc1ccccc1Cl)c1ccc(-c2ccc(Cl)cc2)o1		CHEMBL3753900		IC50			CHEMBL4527	Homo sapiens	IC50		
Not Determined	16433813	CHEMBL3756566	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate after 1 hr in presence of 30 uM ATP	B	Cc1cc([N+](=O)[O-])ccc1-c1ccc(C(=O)Nc2cccc(Cl)c2N2CCOCC2)o1		CHEMBL3754714		IC50			CHEMBL4527	Homo sapiens	IC50		
Not Determined	16433814	CHEMBL3756566	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate after 1 hr in presence of 30 uM ATP	B	O=C(Nc1cccc(Cl)c1N1CCCCC1)c1ccc(-c2ccc(F)cc2)o1		CHEMBL3754752		IC50			CHEMBL4527	Homo sapiens	IC50		
Not Determined	16433815	CHEMBL3756566	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate after 1 hr in presence of 30 uM ATP	B	O=C(Nc1cccc(NC(=O)c2ccc(Cl)cc2Cl)c1)c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL3754520		IC50			CHEMBL4527	Homo sapiens	IC50		
Not Determined	16433816	CHEMBL3756566	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate after 1 hr in presence of 30 uM ATP	B	Cc1ccccc1C(=O)N1CCN(c2ccc(NC(=O)c3ccc(-c4ccc(Cl)cc4)o3)cc2)CC1		CHEMBL3752215		IC50			CHEMBL4527	Homo sapiens	IC50		
Not Determined	16433817	CHEMBL3756566	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate after 1 hr in presence of 30 uM ATP	B	O=C(Nc1cc(Cl)cc(Cl)c1)c1ccc(-c2ccc([N+](=O)[O-])cc2)o1		CHEMBL3752894		IC50			CHEMBL4527	Homo sapiens	IC50		
Not Determined	16433818	CHEMBL3756566	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate after 1 hr in presence of 30 uM ATP	B	Cc1cc([N+](=O)[O-])ccc1NC(=O)c1ccc(-c2cccc(Cl)c2Cl)o1		CHEMBL3753859		IC50			CHEMBL4527	Homo sapiens	IC50		
Not Determined	16433819	CHEMBL3756566	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate after 1 hr in presence of 30 uM ATP	B	CC(C)C(=O)Nc1cccc(NC(=O)c2ccc(-c3ccc(Cl)cc3)o2)c1		CHEMBL3752542		IC50			CHEMBL4527	Homo sapiens	IC50		
Not Determined	16433820	CHEMBL3756566	Inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate after 1 hr in presence of 30 uM ATP	B	Cc1cc(C(=O)Nc2cccc(S(=O)(=O)N3CCOCC3)c2)sc1-c1ccccc1		CHEMBL3753236		IC50			CHEMBL4527	Homo sapiens	IC50		
	16433821	CHEMBL3756567	Competitive inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate after 1 hr in presence of 3 uM ATP	B	CN1CCN(c2ccc(NC(=O)c3ccc(-c4cc(Cl)ccc4Cl)o3)cc2)CC1		CHEMBL3754324	=	IC50	nM	394.0	CHEMBL4527	Homo sapiens	IC50	uM	0.394
	16433822	CHEMBL3756567	Competitive inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate after 1 hr in presence of 3 uM ATP	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	IC50	nM	2.0	CHEMBL4527	Homo sapiens	IC50	uM	0.002
	16433823	CHEMBL3756748	Competitive inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate after 1 hr in presence of 30 uM ATP	B	CN1CCN(c2ccc(NC(=O)c3ccc(-c4cc(Cl)ccc4Cl)o3)cc2)CC1		CHEMBL3754324	=	IC50	nM	849.0	CHEMBL4527	Homo sapiens	IC50	uM	0.849
	16433824	CHEMBL3756748	Competitive inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate after 1 hr in presence of 30 uM ATP	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	IC50	nM	8.0	CHEMBL4527	Homo sapiens	IC50	uM	0.008
	16433825	CHEMBL3756749	Competitive inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate after 1 hr in presence of 300 uM ATP	B	CN1CCN(c2ccc(NC(=O)c3ccc(-c4cc(Cl)ccc4Cl)o3)cc2)CC1		CHEMBL3754324	=	IC50	nM	6177.0	CHEMBL4527	Homo sapiens	IC50	uM	6.177
	16433826	CHEMBL3756749	Competitive inhibition of recombinant TNIK (unknown origin) using LRRKtide as substrate after 1 hr in presence of 300 uM ATP	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	IC50	nM	61.0	CHEMBL4527	Homo sapiens	IC50	uM	0.061
Not Active	16433857	CHEMBL3756765	Inhibition of TNIK in human NCI-H1703 cells transfected with lentiviral vector 7TFP assessed as reduction of GSK3 inhibitor X activated TNIK-mediated Wnt/TCF/beta-catenin-dependent transcription at 10 uM after 24 hrs by luciferase reporter assay	B	CN1CCN(c2ccc(NC(=O)c3ccc(-c4cc(Cl)ccc4Cl)o3)cc2)CC1		CHEMBL3754324		Inhibition	%		CHEMBL4527	Homo sapiens	INH		
Not Active	16433858	CHEMBL3756765	Inhibition of TNIK in human NCI-H1703 cells transfected with lentiviral vector 7TFP assessed as reduction of GSK3 inhibitor X activated TNIK-mediated Wnt/TCF/beta-catenin-dependent transcription at 10 uM after 24 hrs by luciferase reporter assay	B	Cc1c(Cl)cccc1-c1ccc(C(=O)Nc2ccc(S(N)(=O)=O)cc2)o1		CHEMBL3752265		Inhibition	%		CHEMBL4527	Homo sapiens	INH		
Active	16433859	CHEMBL3756765	Inhibition of TNIK in human NCI-H1703 cells transfected with lentiviral vector 7TFP assessed as reduction of GSK3 inhibitor X activated TNIK-mediated Wnt/TCF/beta-catenin-dependent transcription at 10 uM after 24 hrs by luciferase reporter assay	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892		Inhibition	%		CHEMBL4527	Homo sapiens	INH		
Active	16433860	CHEMBL3756765	Inhibition of TNIK in human NCI-H1703 cells transfected with lentiviral vector 7TFP assessed as reduction of GSK3 inhibitor X activated TNIK-mediated Wnt/TCF/beta-catenin-dependent transcription at 10 uM after 24 hrs by luciferase reporter assay	B	O=C1[C@H](Cc2ccc(O)cc2)N2C(=O)CCN(C(=O)NCc3ccccc3)[C@H]2CN1Cc1cccc2ccccc12		CHEMBL2312139		Inhibition	%		CHEMBL4527	Homo sapiens	INH		
	16440889	CHEMBL3755432	Inhibition of TNIK in human PBMC at 1 uM	B	Nc1ccc(-c2cnc(N)c(-c3ccc(Cl)cc3)c2)cn1		CHEMBL3754515	>	Inhibition	%	70.0	CHEMBL4527	Homo sapiens	INH	%	70.0
	16440891	CHEMBL3755434	Inhibition of TNIK (unknown origin) in presence of ATP (Km)	B	Nc1ccc(-c2cnc(N)c(-c3ccc(Cl)cc3)c2)cn1		CHEMBL3754515	=	IC50	nM	15.0	CHEMBL4527	Homo sapiens	IC50	nM	15.0
	16474465	CHEMBL3766976	Inhibition of TNIK (unknown origin) by ATP competition assay	B	Cc1ccc(C(=O)Nc2sc(Nc3ccccc3)nc2C(N)=O)cc1		CHEMBL3764451	=	Ki	nM	100.0	CHEMBL4527	Homo sapiens	Ki	nM	100.0
	16527340	CHEMBL3789924	Inhibition of human TNIK at 10 uM	B	CC1(C)CCC(Nc2ncnc3c2nn2ccccc32)CC1		CHEMBL3787247	=	Inhibition	%	58.8	CHEMBL4527	Homo sapiens	INH	%	58.8
319423	17699420	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	CC(=O)Nc1ccc(C(=O)Nc2sc(Nc3cccc4ccccc34)nc2C(N)=O)cc1		CHEMBL3683982	=	IC50	nM	24.7	CHEMBL4527	Homo sapiens	IC50	nM	24.7
319424	17699421	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	CC(=O)Nc1ccc(C(=O)Nc2sc(Nc3ccc4ccccc4c3)nc2C(N)=O)cc1		CHEMBL3683983	=	IC50	nM	19.8	CHEMBL4527	Homo sapiens	IC50	nM	19.8
319425	17699422	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	COc1ccc(C(=O)Nc2sc(Nc3ccc4ncccc4c3)nc2C(N)=O)cc1		CHEMBL3683984	=	IC50	nM	21.5	CHEMBL4527	Homo sapiens	IC50	nM	21.5
319426	17699423	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	Cc1ccc(C(=O)Nc2sc(Nc3ccc4ccccc4c3)nc2C(N)=O)cc1N		CHEMBL3683985	=	IC50	nM	27.2	CHEMBL4527	Homo sapiens	IC50	nM	27.2
319427	17699424	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccc3ccccc3c2)sc1NC(=O)c1ccc(NCCO)cc1		CHEMBL3683986	=	IC50	nM	10.6	CHEMBL4527	Homo sapiens	IC50	nM	10.6
319428	17699425	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	CN(C)CCNc1ccc(C(=O)Nc2sc(Nc3ccc4ccccc4c3)nc2C(N)=O)cc1		CHEMBL3683987	=	IC50	nM	8.6	CHEMBL4527	Homo sapiens	IC50	nM	8.6
319429	17699426	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	CN1CCN(c2ccc(C(=O)Nc3sc(Nc4ccc5ccccc5c4)nc3C(N)=O)cc2)CC1		CHEMBL3683988	=	IC50	nM	10.2	CHEMBL4527	Homo sapiens	IC50	nM	10.2
319430	17699427	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccc3ccccc3c2)sc1NC(=O)c1ccc(NCCN2CCCCC2)cc1		CHEMBL3683989	=	IC50	nM	8.0	CHEMBL4527	Homo sapiens	IC50	nM	8.0
319431	17699428	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccc3ccccc3c2)sc1NC(=O)c1ccc(N)cc1		CHEMBL3683990	=	IC50	nM	20.3	CHEMBL4527	Homo sapiens	IC50	nM	20.3
319432	17699429	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	CN1CCN(Cc2ccc(C(=O)Nc3sc(Nc4ccc5ccccc5c4)nc3C(N)=O)cc2)CC1		CHEMBL3683991	=	IC50	nM	5.1	CHEMBL4527	Homo sapiens	IC50	nM	5.1
319433	17699430	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccc3ccccc3c2)sc1NC(=O)c1ccc(CN2CCOCC2)cc1		CHEMBL3683992	=	IC50	nM	8.6	CHEMBL4527	Homo sapiens	IC50	nM	8.6
319434	17699431	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NCc1ccc(C(=O)Nc2sc(Nc3ccc4ccccc4c3)nc2C(N)=O)cc1		CHEMBL3683993	=	IC50	nM	5.3	CHEMBL4527	Homo sapiens	IC50	nM	5.3
319435	17699432	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	CN1CCN(c2ccc(C(=O)Nc3sc(Nc4ccc5ncccc5c4)nc3C(N)=O)cc2)CC1		CHEMBL3683994	=	IC50	nM	4.1	CHEMBL4527	Homo sapiens	IC50	nM	4.1
319436	17699433	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	CN1CCN(c2ccc(C(=O)Nc3sc(Nc4cccc5ncccc45)nc3C(N)=O)cc2)CC1		CHEMBL3683995	=	IC50	nM	15.6	CHEMBL4527	Homo sapiens	IC50	nM	15.6
319437	17699434	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	CN1CCN(c2ccc(C(=O)Nc3sc(Nc4cccc5cccnc45)nc3C(N)=O)cc2)CC1		CHEMBL3683996	=	IC50	nM	19.1	CHEMBL4527	Homo sapiens	IC50	nM	19.1
319438	17699435	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	CN1CCN(c2ccc(C(=O)Nc3sc(N(C)c4ccc5ncccc5c4)nc3C(N)=O)cc2)CC1		CHEMBL3683997	=	IC50	nM	17.0	CHEMBL4527	Homo sapiens	IC50	nM	17.0
319439	17699436	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	CN(CCO)c1ccc(C(=O)Nc2sc(Nc3ccc4ccccc4c3)nc2C(N)=O)cc1		CHEMBL3683998	=	IC50	nM	27.4	CHEMBL4527	Homo sapiens	IC50	nM	27.4
319440	17699437	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	CC(O)CNc1ccc(C(=O)Nc2sc(Nc3ccc4ccccc4c3)nc2C(N)=O)cc1		CHEMBL3683999	=	IC50	nM	10.7	CHEMBL4527	Homo sapiens	IC50	nM	10.7
319441	17699438	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccc3ccccc3c2)sc1NC(=O)c1ccc[nH]1		CHEMBL3684000	=	IC50	nM	7.5	CHEMBL4527	Homo sapiens	IC50	nM	7.5
319442	17699439	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccc3ccccc3c2)sc1NC(=O)c1cc2sccc2[nH]1		CHEMBL3684001	=	IC50	nM	22.7	CHEMBL4527	Homo sapiens	IC50	nM	22.7
319443	17699440	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2cccc3ncccc23)sc1NC(=O)c1ccsc1		CHEMBL3684002	=	IC50	nM	9.4	CHEMBL4527	Homo sapiens	IC50	nM	9.4
319444	17699441	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccc3cnccc3c2)sc1NC(=O)c1ccsc1		CHEMBL3684003	=	IC50	nM	12.0	CHEMBL4527	Homo sapiens	IC50	nM	12.0
319445	17699442	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	CN(c1ccc2ncccc2c1)c1nc(C(N)=O)c(NC(=O)c2csc(CN3CCOCC3)c2)s1		CHEMBL3684004	=	IC50	nM	5.7	CHEMBL4527	Homo sapiens	IC50	nM	5.7
319446	17699443	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	CN1CCN(Cc2cc(C(=O)Nc3sc(Nc4cccc5ncccc45)nc3C(N)=O)cs2)CC1		CHEMBL3684005	=	IC50	nM	8.2	CHEMBL4527	Homo sapiens	IC50	nM	8.2
319447	17699444	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	CN1CCN(c2ccc(C(=O)Nc3sc(N(C)c4ccc5ccccc5c4)nc3C(N)=O)cc2)CC1		CHEMBL3684006	=	IC50	nM	36.3	CHEMBL4527	Homo sapiens	IC50	nM	36.3
319448	17699445	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccc3cc(CO)ccc3c2)sc1NC(=O)c1ccsc1		CHEMBL3684007	=	IC50	nM	5.5	CHEMBL4527	Homo sapiens	IC50	nM	5.5
319449	17699446	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	COc1cc(Nc2nc(C(N)=O)c(NC(=O)c3ccsc3)s2)cc2ccccc12		CHEMBL3684008	=	IC50	nM	51.3	CHEMBL4527	Homo sapiens	IC50	nM	51.3
319450	17699447	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccc3ccc(F)cc3c2)sc1NC(=O)c1ccsc1		CHEMBL3684009	=	IC50	nM	16.9	CHEMBL4527	Homo sapiens	IC50	nM	16.9
319451	17699448	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	CC(C)=CC(=O)Nc1sc(Nc2ccc3ccccc3c2)nc1C(N)=O		CHEMBL3684010	=	IC50	nM	12.7	CHEMBL4527	Homo sapiens	IC50	nM	12.7
319452	17699449	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccc3ccccc3c2)sc1NC(=O)CCCCCN1CCOCC1		CHEMBL3684011	=	IC50	nM	20.2	CHEMBL4527	Homo sapiens	IC50	nM	20.2
319453	17699450	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccc3ccccc3c2)sc1NC(=O)C1CC1		CHEMBL3684012	=	IC50	nM	15.0	CHEMBL4527	Homo sapiens	IC50	nM	15.0
319454	17699451	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccc3ccccc3c2)sc1NC(=O)c1ccc(N2CCC(O)CC2)cc1		CHEMBL3684013	=	IC50	nM	12.7	CHEMBL4527	Homo sapiens	IC50	nM	12.7
319455	17699452	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccc3cc(F)ccc3c2)sc1NC(=O)c1ccc(NCCO)cc1		CHEMBL3684014	=	IC50	nM	22.5	CHEMBL4527	Homo sapiens	IC50	nM	22.5
319456	17699453	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	COc1ccc2cc(Nc3nc(C(N)=O)c(NC(=O)c4ccc(NCCO)cc4)s3)ccc2c1		CHEMBL3684015	=	IC50	nM	14.8	CHEMBL4527	Homo sapiens	IC50	nM	14.8
319457	17699454	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccc3ccccc3c2)sc1NC(=O)c1ccc(CCO)cc1		CHEMBL3684016	=	IC50	nM	5.8	CHEMBL4527	Homo sapiens	IC50	nM	5.8
319458	17699455	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccc3ccccc3c2)sc1NC(=O)c1ccc(NCCO)c(N)c1		CHEMBL3684017	=	IC50	nM	24.4	CHEMBL4527	Homo sapiens	IC50	nM	24.4
319459	17699456	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccc3ccc(F)cc3c2)sc1NC(=O)C1CC1		CHEMBL3684018	=	IC50	nM	12.8	CHEMBL4527	Homo sapiens	IC50	nM	12.8
319460	17699457	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccc3ccc(F)cc3c2)sc1NC(=O)c1ccc(NCCO)cc1		CHEMBL3684019	=	IC50	nM	12.9	CHEMBL4527	Homo sapiens	IC50	nM	12.9
319461	17699458	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	CC(C)=CC(=O)Nc1sc(Nc2ccc3ccc(F)cc3c2)nc1C(N)=O		CHEMBL3684020	=	IC50	nM	7.2	CHEMBL4527	Homo sapiens	IC50	nM	7.2
319462	17699459	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccc3ccc(F)cc3c2)sc1NC(=O)CCCCCN1CCOCC1		CHEMBL3684021	=	IC50	nM	19.5	CHEMBL4527	Homo sapiens	IC50	nM	19.5
319463	17699460	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	COc1ccc2cc(Nc3nc(C(N)=O)c(NC(=O)c4ccc(N)cc4)s3)ccc2c1		CHEMBL3684022	=	IC50	nM	9.7	CHEMBL4527	Homo sapiens	IC50	nM	9.7
319464	17699461	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	COc1ccc2cc(Nc3nc(C(N)=O)c(NC(=O)C=C(C)C)s3)ccc2c1		CHEMBL3684023	=	IC50	nM	15.2	CHEMBL4527	Homo sapiens	IC50	nM	15.2
319465	17699462	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccc3cc(CO)ccc3c2)sc1NC(=O)C1CC1		CHEMBL3684024	=	IC50	nM	5.8	CHEMBL4527	Homo sapiens	IC50	nM	5.8
319466	17699463	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	CC(C)=CC(=O)Nc1sc(Nc2ccc3cc(CO)ccc3c2)nc1C(N)=O		CHEMBL3684025	=	IC50	nM	1.6	CHEMBL4527	Homo sapiens	IC50	nM	1.6
319467	17699464	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	C[C@H](O)CNc1ccc(C(=O)Nc2sc(Nc3ccc4ccccc4c3)nc2C(N)=O)cc1		CHEMBL3684026	=	IC50	nM	15.1	CHEMBL4527	Homo sapiens	IC50	nM	15.1
319468	17699465	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	C[C@@H](O)CNc1ccc(C(=O)Nc2sc(Nc3ccc4ccccc4c3)nc2C(N)=O)cc1		CHEMBL3684027	=	IC50	nM	16.8	CHEMBL4527	Homo sapiens	IC50	nM	16.8
319469	17699466	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	Cc1ccc(C(=O)Nc2sc(Nc3ccc4cc(CO)ccc4c3)nc2C(N)=O)s1		CHEMBL3684028	=	IC50	nM	11.1	CHEMBL4527	Homo sapiens	IC50	nM	11.1
319470	17699467	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccc3ccccc3c2)sc1NC(=O)c1ccc(CNCCO)cc1		CHEMBL3684029	=	IC50	nM	3.7	CHEMBL4527	Homo sapiens	IC50	nM	3.7
319471	17699468	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	CC#CC(=O)Nc1sc(Nc2ccc3ccccc3c2)nc1C(N)=O		CHEMBL3684030	=	IC50	nM	4.4	CHEMBL4527	Homo sapiens	IC50	nM	4.4
319472	17699469	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccc3ccccc3c2)sc1NC(=O)c1ccc(CN2CCC(O)CC2)cc1		CHEMBL3684031	=	IC50	nM	3.4	CHEMBL4527	Homo sapiens	IC50	nM	3.4
319473	17699470	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	CN1CCN(C/C=C/C(=O)Nc2sc(Nc3ccc4ccccc4c3)nc2C(N)=O)CC1		CHEMBL3684032	=	IC50	nM	16.0	CHEMBL4527	Homo sapiens	IC50	nM	16.0
319474	17699471	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccc3ccccc3c2)sc1NC(=O)c1ccc(CN2CCNC(=O)C2)cc1		CHEMBL3684033	=	IC50	nM	4.2	CHEMBL4527	Homo sapiens	IC50	nM	4.2
319475	17699472	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccc3ccccc3c2)sc1NC(=O)c1ccc(CN2CCN(CCO)CC2)cc1		CHEMBL3684034	=	IC50	nM	2.7	CHEMBL4527	Homo sapiens	IC50	nM	2.7
319476	17699473	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccc3ccccc3c2)sc1NC(=O)c1ccc(N2CCN(CCO)CC2)cc1		CHEMBL3684035	=	IC50	nM	7.2	CHEMBL4527	Homo sapiens	IC50	nM	7.2
319477	17699474	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NCCNc1ccc(C(=O)Nc2sc(Nc3ccc4ccccc4c3)nc2C(N)=O)cc1		CHEMBL3684036	=	IC50	nM	8.4	CHEMBL4527	Homo sapiens	IC50	nM	8.4
319478	17699475	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccc3ccccc3c2)sc1NC(=O)c1ccc(CN2CCCCC2CO)cc1		CHEMBL3684037	=	IC50	nM	6.8	CHEMBL4527	Homo sapiens	IC50	nM	6.8
319479	17699476	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	CN1CCCN(Cc2ccc(C(=O)Nc3sc(Nc4ccc5ccccc5c4)nc3C(N)=O)cc2)CC1		CHEMBL3684038	=	IC50	nM	3.2	CHEMBL4527	Homo sapiens	IC50	nM	3.2
319480	17699477	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccc3ccccc3c2)sc1NC(=O)c1ccc(Cn2cncn2)cc1		CHEMBL3684039	=	IC50	nM	2.5	CHEMBL4527	Homo sapiens	IC50	nM	2.5
319481	17699478	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccc3ccccc3c2)sc1NC(=O)c1ccc(CN2CC(O)C2)cc1		CHEMBL3684040	=	IC50	nM	5.6	CHEMBL4527	Homo sapiens	IC50	nM	5.6
319482	17699479	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccc3ccccc3c2)sc1NC(=O)c1ccc(CN2CC[C@@H](O)C2)cc1		CHEMBL3684041	=	IC50	nM	5.5	CHEMBL4527	Homo sapiens	IC50	nM	5.5
319483	17699480	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccc3ccccc3c2)sc1NC(=O)c1ccc(CN2CC[C@H](O)C2)cc1		CHEMBL3684042	=	IC50	nM	5.0	CHEMBL4527	Homo sapiens	IC50	nM	5.0
319484	17699481	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	C#CC(=O)Nc1sc(Nc2ccc3ccccc3c2)nc1C(N)=O		CHEMBL3684043	=	IC50	nM	6.0	CHEMBL4527	Homo sapiens	IC50	nM	6.0
319485	17699482	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccc3ccccc3c2)sc1NC(=O)c1ccc(Cn2cnnn2)cc1		CHEMBL3684044	=	IC50	nM	5.9	CHEMBL4527	Homo sapiens	IC50	nM	5.9
319486	17699483	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccc3ccccc3c2)sc1NC(=O)c1ccc(Cn2ccnc2)cc1		CHEMBL3684045	=	IC50	nM	3.0	CHEMBL4527	Homo sapiens	IC50	nM	3.0
319487	17699484	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccc3ccccc3c2)sc1NC(=O)C#CCO		CHEMBL3684046	=	IC50	nM	4.5	CHEMBL4527	Homo sapiens	IC50	nM	4.5
319488	17699485	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccc3ccccc3c2)sc1NC(=O)c1ccc(CN2CC[C@H](N)C2)cc1		CHEMBL3684047	=	IC50	nM	3.0	CHEMBL4527	Homo sapiens	IC50	nM	3.0
319489	17699486	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	CN(C)[C@H]1CCN(Cc2ccc(C(=O)Nc3sc(Nc4ccc5ccccc5c4)nc3C(N)=O)cc2)C1		CHEMBL3684048	=	IC50	nM	2.6	CHEMBL4527	Homo sapiens	IC50	nM	2.6
319490	17699487	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccc3ccccc3c2)sc1NC(=O)c1ccc(CN2CCC(N)CC2)cc1		CHEMBL3684049	=	IC50	nM	1.3	CHEMBL4527	Homo sapiens	IC50	nM	1.3
319491	17699488	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccc3ccccc3c2)sc1NC(=O)C#CCCO		CHEMBL3684050	=	IC50	nM	4.0	CHEMBL4527	Homo sapiens	IC50	nM	4.0
319492	17699489	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccc3ccccc3c2)sc1NC(=O)c1ccc(Cc2nn[nH]n2)cc1		CHEMBL3684051	=	IC50	nM	2.9	CHEMBL4527	Homo sapiens	IC50	nM	2.9
319493	17699490	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccc3ccccc3c2)sc1NC(=O)c1ccc(Cn2cccn2)cc1		CHEMBL3684052	=	IC50	nM	10.3	CHEMBL4527	Homo sapiens	IC50	nM	10.3
319494	17699491	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccc3ccccc3c2)sc1NC(=O)C#CCCCn1cncn1		CHEMBL3684053	=	IC50	nM	10.7	CHEMBL4527	Homo sapiens	IC50	nM	10.7
319495	17699492	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccc3ccccc3c2)sc1NC(=O)C#CCCCn1ccnc1		CHEMBL3684054	=	IC50	nM	9.7	CHEMBL4527	Homo sapiens	IC50	nM	9.7
319496	17699493	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccc3ccccc3c2)sc1NC(=O)c1ccc(Cn2ccnc2[N+](=O)[O-])cc1		CHEMBL3684055	=	IC50	nM	9.5	CHEMBL4527	Homo sapiens	IC50	nM	9.5
319497	17699494	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	Cc1nccn1Cc1ccc(C(=O)Nc2sc(Nc3ccc4ccccc4c3)nc2C(N)=O)cc1		CHEMBL3684056	=	IC50	nM	2.3	CHEMBL4527	Homo sapiens	IC50	nM	2.3
319498	17699495	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	Cc1cn(Cc2ccc(C(=O)Nc3sc(Nc4ccc5ccccc5c4)nc3C(N)=O)cc2)cn1		CHEMBL3684057	=	IC50	nM	3.1	CHEMBL4527	Homo sapiens	IC50	nM	3.1
319499	17699496	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccc3ccccc3c2)sc1NC(=O)c1ccc(Cn2cnc([N+](=O)[O-])c2)cc1		CHEMBL3684058	=	IC50	nM	5.9	CHEMBL4527	Homo sapiens	IC50	nM	5.9
319500	17699497	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccc3ccccc3c2)sc1NC(=O)c1ccc(Cn2cnc([N+](=O)[O-])n2)cc1		CHEMBL3684059	=	IC50	nM	14.8	CHEMBL4527	Homo sapiens	IC50	nM	14.8
319501	17699498	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	Cc1nnnn1Cc1ccc(C(=O)Nc2sc(Nc3ccc4ccccc4c3)nc2C(N)=O)cc1		CHEMBL3684060	=	IC50	nM	7.1	CHEMBL4527	Homo sapiens	IC50	nM	7.1
319502	17699499	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccc3ccccc3c2)sc1NC(=O)c1ccc(Cn2cnc(CO)c2)cc1		CHEMBL3684061	=	IC50	nM	3.5	CHEMBL4527	Homo sapiens	IC50	nM	3.5
319503	17699500	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	COc1ccc2cc(Nc3nc(C(N)=O)c(NC(=O)c4ccc(Cn5ccnc5)cc4)s3)ccc2c1		CHEMBL3639829	=	IC50	nM	6.1	CHEMBL4527	Homo sapiens	IC50	nM	6.1
319504	17699501	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccc3cc(F)ccc3c2)sc1NC(=O)c1ccc(Cn2ccnc2)cc1		CHEMBL3684062	=	IC50	nM	10.1	CHEMBL4527	Homo sapiens	IC50	nM	10.1
319505	17699502	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccc3ncccc3c2)sc1NC(=O)c1ccc(Cn2ccnc2)cc1		CHEMBL3684063	=	IC50	nM	3.0	CHEMBL4527	Homo sapiens	IC50	nM	3.0
319506	17699503	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccc3ccccc3c2)sc1NC(=O)c1ccc(Cn2ccnc2)s1		CHEMBL3684064	=	IC50	nM	7.7	CHEMBL4527	Homo sapiens	IC50	nM	7.7
319507	17699504	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccc3ccccc3c2)sc1NC(=O)c1ccc(CN2C(=O)CSC2=O)cc1		CHEMBL3684065	=	IC50	nM	15.9	CHEMBL4527	Homo sapiens	IC50	nM	15.9
319508	17699505	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2cccc3ncccc23)sc1NC(=O)c1ccc(Cn2ccnc2)cc1		CHEMBL3684066	=	IC50	nM	4.8	CHEMBL4527	Homo sapiens	IC50	nM	4.8
319509	17699506	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccnc3ccccc23)sc1NC(=O)c1ccc(Cn2ccnc2)cc1		CHEMBL3684067	=	IC50	nM	26.5	CHEMBL4527	Homo sapiens	IC50	nM	26.5
319510	17699507	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	Cc1noc(Cc2ccc(C(=O)Nc3sc(Nc4ccc5ccccc5c4)nc3C(N)=O)cc2)n1		CHEMBL3684068	=	IC50	nM	18.5	CHEMBL4527	Homo sapiens	IC50	nM	18.5
319511	17699508	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	Cc1nnc(Cc2ccc(C(=O)Nc3sc(Nc4ccc5ccccc5c4)nc3C(N)=O)cc2)o1		CHEMBL3684069	=	IC50	nM	6.2	CHEMBL4527	Homo sapiens	IC50	nM	6.2
319512	17699509	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccc3ccccc3c2)sc1NC(=O)c1csc(Cn2ccnc2)c1		CHEMBL3684070	=	IC50	nM	8.7	CHEMBL4527	Homo sapiens	IC50	nM	8.7
319513	17699510	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2cccc3cccnc23)sc1NC(=O)c1ccc(Cn2ccnc2)cc1		CHEMBL3684071	=	IC50	nM	5.5	CHEMBL4527	Homo sapiens	IC50	nM	5.5
319514	17699511	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccc3ccccc3c2)sc1NC(=O)c1ccc(Cn2cc(CO)nn2)cc1		CHEMBL3684072	=	IC50	nM	5.3	CHEMBL4527	Homo sapiens	IC50	nM	5.3
319515	17699512	CHEMBL3705651	"Kinase Assay: The kinase assays were conducted in a 20 μl volume using 384-well plates (Greiner). The reaction mixture consists of compound or vehicle (1% DMSO), 0.08 ng/μl TNIK_N, 1 μM FITC-labeled substrate peptides, including ε-aminocaproic acid and 7 amino acids (described as SEQ ID NO. 3 in ""Kinase assay of TEST EXAMPLE 1"" of WO 2010/064111(P.31)), 20 mM Hepes, pH 7.5, 0.01% Triton X-100, 5 mM MgCl2, 25 μM ATP and 2 mM DTT. As blank, TNIK_N was excluded from the reaction mixture of vehicle (1% DMSO). The kinase reaction was carried out 1 h at room temperature and terminated by addition of 60 μl of the termination buffer (127 mM Hepes, pH 7.5, 26.7 mM EDTA, 0.01% Triton X-100, 1% DMSO and 0.13% Coating Reagent 3 (Caliper Life Sciences)). The amount of unphosphorylated and phosphorylated FITC-labeled substrate peptides was detected by Mobility Shift Micro Fluidic Technology (Caliper LC3000 System, Caliper Life Sciences)."	B	NC(=O)c1nc(Nc2ccc3ccc(F)cc3c2)sc1NC(=O)c1ccc(Cn2ccnc2)cc1		CHEMBL3684073	=	IC50	nM	8.4	CHEMBL4527	Homo sapiens	IC50	nM	8.4
Inactive	17945193	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945194	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Active	17945195	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	=	Kd	nM	1247.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	1247.0
Inactive	17945196	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945197	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945198	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Active	17945199	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	Kd	nM	801.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	801.0
Inactive	17945200	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945201	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945202	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945203	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945204	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945205	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945206	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945207	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Active	17945208	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Kd	nM	10.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	10.0
Inactive	17945209	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945210	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17945211	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	=	Kd	nM	107.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	107.0
Inactive	17945212	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945213	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945214	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945215	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Active	17945216	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	=	Kd	nM	94.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	94.0
Inactive	17945217	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945218	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945219	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945220	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945221	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945222	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945223	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945224	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945225	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945226	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Active	17945227	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Kd	nM	746.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	746.0
Inactive	17945228	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945229	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945230	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Active	17945231	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	=	Kd	nM	1881.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	1881.0
Inactive	17945232	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945233	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945234	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945235	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945236	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945237	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945238	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945239	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Active	17945240	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	387.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	387.0
Inactive	17945241	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945242	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945243	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945244	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945245	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945246	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945247	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945248	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945249	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945250	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945251	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945252	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945253	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945254	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945255	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945256	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945257	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945258	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945259	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945260	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945261	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945262	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945263	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945264	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945265	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945266	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945267	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945268	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945269	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945270	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945271	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945272	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945273	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945274	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945275	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Active	17945276	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	3787.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	3787.0
Inactive	17945277	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17945278	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	=	Kd	nM	89.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	89.0
Inactive	17945279	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Active	17945280	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	=	Kd	nM	2343.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	2343.0
Inactive	17945281	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945282	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945283	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Active	17945284	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	=	Kd	nM	565.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	565.0
Inactive	17945285	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945286	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945287	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945288	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945289	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945290	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945291	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17945292	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	=	Kd	nM	38.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	38.0
Uncertain	17945293	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	1262.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	1262.0
Inactive	17945294	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945295	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945296	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945297	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945298	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Active	17945299	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Kd	nM	2135.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	2135.0
Inactive	17945300	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Active	17945301	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	291.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	291.0
Inactive	17945302	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945303	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945304	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945305	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945306	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945307	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945308	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945309	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945310	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945311	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945312	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945313	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945314	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945315	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945316	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945317	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945318	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945319	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945320	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945321	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945322	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945323	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Active	17945324	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	1300.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	1300.0
Inactive	17945325	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945326	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945327	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945328	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945329	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945330	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945331	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17945332	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	=	Kd	nM	251.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	251.0
Inactive	17945333	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945334	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945335	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945336	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17945337	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	=	Kd	nM	184.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	184.0
Inactive	17945338	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945339	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945340	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945341	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945342	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945343	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945344	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17945345	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	=	Kd	nM	1208.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	1208.0
Inactive	17945346	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945347	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945348	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Active	17945349	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Kd	nM	1770.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	1770.0
Inactive	17945350	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17945351	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	=	Kd	nM	1387.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	1387.0
Inactive	17945352	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945353	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945354	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945355	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945356	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945357	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945358	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945359	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945360	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Active	17945361	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	Kd	nM	385.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	385.0
Inactive	17945362	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945363	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945364	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945365	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945366	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945367	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945368	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945369	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945370	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945371	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945372	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945373	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945374	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945375	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945376	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945377	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945378	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Active	17945379	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	1130.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	1130.0
Inactive	17945380	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17945381	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	23.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	23.0
Inactive	17945382	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945383	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945384	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Active	17945385	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	=	Kd	nM	1375.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	1375.0
Inactive	17945386	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945387	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945388	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17945389	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	Kd	nM	12.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	12.0
Inactive	17945390	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945391	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945392	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945393	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945394	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945395	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945396	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945397	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945398	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945399	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945400	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945401	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945402	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945403	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945404	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945405	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945406	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945407	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945408	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945409	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945410	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945411	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945412	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945413	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945414	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945415	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945416	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945417	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945418	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945419	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945420	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945421	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945422	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945423	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945424	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17945425	CHEMBL3991912	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL4527	Homo sapiens	Kd apparent	nM	30000.0
	18114885	CHEMBL4025415	Inhibition of wild-type human partial length TNIK (D4 to K311 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	97.0	CHEMBL4527	Homo sapiens	Activity	%	97.0
Active	18149682	CHEMBL4033358	Inhibition of human TNIK at 0.5 uM relative to control	B	COc1cc2ncnc(Oc3ccc(NC(=O)Nc4ccc(CN5CCOCC5)c(C(F)(F)F)c4)c4ccccc34)c2cc1OC		CHEMBL4075561		Inhibition	%		CHEMBL4527	Homo sapiens	INH		
Active	18149683	CHEMBL4033358	Inhibition of human TNIK at 0.5 uM relative to control	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Inhibition	%		CHEMBL4527	Homo sapiens	INH		
	18203939	CHEMBL4044226	Inhibition of wild-type human partial length TNIK (D4 to K311 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	94.0	CHEMBL4527	Homo sapiens	Activity	%	94.0
	18212073	CHEMBL4046114	Inhibition of ZC2/TNIK conserved Lys2 (DIKGQNVLLTENAEVK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	29.1	CHEMBL4527	Homo sapiens	INH	%	29.1
	18212074	CHEMBL4046113	Inhibition of ZC2/TNIK conserved Lys2 (DIKGQNVLLTENAEVK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	14.5	CHEMBL4527	Homo sapiens	INH	%	14.5
	18253379	CHEMBL4054973	Inhibition of wild-type human partial length TNIK (D4 to K311 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	66.0	CHEMBL4527	Homo sapiens	Activity	%	66.0
	18253380	CHEMBL4054973	Inhibition of wild-type human partial length TNIK (D4 to K311 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	93.0	CHEMBL4527	Homo sapiens	Activity	%	93.0
	18275361	CHEMBL4118499	Inhibition of ZC2/TNIK in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DIKGQNVLLTENAEVK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	Inhibition	%	6.8	CHEMBL4527	Homo sapiens	INH	%	6.8
	18275362	CHEMBL4118499	Inhibition of ZC2/TNIK in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DIKGQNVLLTENAEVK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839	=	Inhibition	%	20.9	CHEMBL4527	Homo sapiens	INH	%	20.9
	18275363	CHEMBL4118499	Inhibition of ZC2/TNIK in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled DIKGQNVLLTENAEVK probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Inhibition	%	15.1	CHEMBL4527	Homo sapiens	INH	%	15.1
	18440481	CHEMBL4157305	Binding affinity to wild-type human partial length TNIK (D4 to K311 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	100.0	CHEMBL4527	Homo sapiens	Activity	%	100.0
	18484437	CHEMBL4186084	Binding affinity to wild-type human partial length TNIK (D4 to K311 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	100.0	CHEMBL4527	Homo sapiens	Activity	%	100.0
	18484921	CHEMBL4186084	Binding affinity to wild-type human partial length TNIK (D4 to K311 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	100.0	CHEMBL4527	Homo sapiens	Activity	%	100.0
Active	18499344	CHEMBL4188994	Inhibition of wild-type human partial length TNIK (D4 to K311 residues) expressed in bacterial expression system at 1 uM using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCN(C)CC4)cc3)nn(CC3CCCC3)c2n1		CHEMBL4218175		Inhibition	%		CHEMBL4527	Homo sapiens	INH		
	18507576	CHEMBL4191215	Inhibition of recombinant human TNIK (1 to 367 residues) at 1 uM using RLGRDKYKTLRQIRQ as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	-9.0	CHEMBL4527	Homo sapiens	INH	%	-9.0
	18653329	CHEMBL4230241	Inhibition of TNIK (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	71.0	CHEMBL4527	Homo sapiens	INH	%	71.0
	18653330	CHEMBL4230241	Inhibition of TNIK (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	4.0	CHEMBL4527	Homo sapiens	INH	%	4.0
	18655251	CHEMBL4230984	Binding affinity to wild-type human partial length TNIK (D4 to K311 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	83.0	CHEMBL4527	Homo sapiens	Activity	%	83.0
	18751254	CHEMBL4263963	Inhibition of TNIK (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	95.0	CHEMBL4527	Homo sapiens	INH	%	95.0
	18752236	CHEMBL4264573	Binding affinity to wild-type human partial length TNIK (D4 to K311 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	64.0	CHEMBL4527	Homo sapiens	Activity	%	64.0
	18858236	CHEMBL4308082	Binding affinity to wild-type human partial length TNIK (D4 to K311 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	100.0	CHEMBL4527	Homo sapiens	Activity	%	100.0
	18892730	CHEMBL4314519	Inhibition of human TNIK (1 to 367 residues) using RLGRDKYKTLRQIRQ as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	108.0	CHEMBL4527	Homo sapiens	Activity	%	108.0
	18919513	CHEMBL4322870	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged TNIK (unknown origin) (1 to 314 residues) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	121.0	CHEMBL4527	Homo sapiens	Kd	nM	121.0
	18919701	CHEMBL4322870	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged TNIK (unknown origin) (1 to 314 residues) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	97.0	CHEMBL4527	Homo sapiens	Kd	nM	97.0
	18938361	CHEMBL4327907	Inhibition of human TNIK assessed as residual activity at 1 uM using RLGRDKYKTLRQIRQ as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	95.89	CHEMBL4527	Homo sapiens	Activity	%	95.89
	18938362	CHEMBL4327907	Inhibition of human TNIK assessed as residual activity at 1 uM using RLGRDKYKTLRQIRQ as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	89.34	CHEMBL4527	Homo sapiens	Activity	%	89.34
	18938752	CHEMBL4328271	Inhibition of human TNIK assessed as residual activity at 100 uM using RLGRDKYKTLRQIRQ as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL4527	Homo sapiens	Activity	%	65.0
	18939139	CHEMBL4328635	Inhibition of human TNIK using RLGRDKYKTLRQIRQ as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.551	CHEMBL4527	Homo sapiens	IC50	10'-10M	5.51
	18959008	CHEMBL4333664	Binding affinity to wild-type human partial length TNIK (D4 to K311 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	62.0	CHEMBL4527	Homo sapiens	Activity	%	62.0
	18964757	CHEMBL4335320	Inhibition of human TNIK (1 to 367 residues) assessed as residual activity at 1 uM using RLGRDKYKTLRQIRQ as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	74.0	CHEMBL4527	Homo sapiens	Activity	%	74.0
	18964758	CHEMBL4335320	Inhibition of human TNIK (1 to 367 residues) assessed as residual activity at 1 uM using RLGRDKYKTLRQIRQ as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	52.0	CHEMBL4527	Homo sapiens	Activity	%	52.0
	18972134	CHEMBL4337144	Inhibition of human TNIK (1 to 367 residues) assessed as residual activity at 10 uM using RLGRDKYKTLRQIRQ as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	16.0	CHEMBL4527	Homo sapiens	Activity	%	16.0
Not Active	19040192	CHEMBL4352092	Inhibition of human TNIK (1 to 367 residues) using RLGRDKYKTLRQIRQ as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL4527	Homo sapiens	INH		
Active	19041309	CHEMBL4352570	Inhibition of human TNIK at 10 uM using RLGRDKYKTLRQIRQ as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL4527	Homo sapiens	INH		
	19059861	CHEMBL4358162	Binding affinity to wild-type human partial length TNIK (D4 to K311 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL4527	Homo sapiens	Activity	%	100.0
	19090425	CHEMBL4365999	Inhibition of wild-type human partial length TNIK (D4 to K311 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	72.0	CHEMBL4527	Homo sapiens	Activity	%	72.0
	19092147	CHEMBL4366621	Inhibition of human TNIK at 100 nM using RLGRDKYKTLRQIRQ as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	15.61	CHEMBL4527	Homo sapiens	INH	%	15.61
	19144914	CHEMBL4377930	Inhibition of human TNIK (1 to 367 residues) at 1 uM using RLGRDKYKTLRQIRQ as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	69.0	CHEMBL4527	Homo sapiens	INH	%	69.0
	19148071	CHEMBL4379467	Inhibition of human TNIK (1 to 367 residues) using RLGRDKYKTLRQI as substrate incubated for 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL4527	Homo sapiens	IC50	uM	10.0
	19159689	CHEMBL4382793	Binding affinity to wild-type human partial length TNIK (D4 to K311 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	61.0	CHEMBL4527	Homo sapiens	Activity	%	61.0
	19191318	CHEMBL4389512	Inhibition of wild-type human partial length TNIK (D4 to K311 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	26.0	CHEMBL4527	Homo sapiens	INH	%	26.0
	19192175	CHEMBL4389989	Inhibition of wild-type human partial length TNIK (D4 to K311 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	81.0	CHEMBL4527	Homo sapiens	INH	%	81.0
	19200431	CHEMBL4391615	Binding affinity to wild-type human partial length TNIK (D4 to K311 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	48.0	CHEMBL4527	Homo sapiens	Activity	%	48.0
	19266646	CHEMBL4405596	Inhibition of wild-type human partial length TNIK (D4 to K311 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL4527	Homo sapiens	INH	%	50.0
	19452090	CHEMBL4434088	Inhibition of human full length TNIK(1-1360)-G5-Avi-6His-Flag expressed in baculovirus-infected sf21 cells using His6-SMAD1 as substrate preincubated for 30 mins followed by substrate addition and measured after 120 mins by ADP-Glo Reagent based method	B	CC(C)NC(=O)c1ccc(-c2cnc(N(C)C)c(-c3ccc(C#N)cc3)c2)cc1		CHEMBL4465524	=	IC50	nM	25118.86	CHEMBL4527	Homo sapiens	pIC50		4.6
	19452091	CHEMBL4434088	Inhibition of human full length TNIK(1-1360)-G5-Avi-6His-Flag expressed in baculovirus-infected sf21 cells using His6-SMAD1 as substrate preincubated for 30 mins followed by substrate addition and measured after 120 mins by ADP-Glo Reagent based method	B	CC(C)NC(=O)c1ccc(-c2cnc(N)c(-c3ccc(C#N)cc3)c2)cc1		CHEMBL4558962	=	IC50	nM	39.81	CHEMBL4527	Homo sapiens	pIC50		7.4
	19452092	CHEMBL4434088	Inhibition of human full length TNIK(1-1360)-G5-Avi-6His-Flag expressed in baculovirus-infected sf21 cells using His6-SMAD1 as substrate preincubated for 30 mins followed by substrate addition and measured after 120 mins by ADP-Glo Reagent based method	B	CN(C)c1ncc(-c2ccc(O)cc2)cc1-c1ccc(S(C)(=O)=O)cc1		CHEMBL4451091	=	IC50	nM	3981.07	CHEMBL4527	Homo sapiens	pIC50		5.4
	19452093	CHEMBL4434088	Inhibition of human full length TNIK(1-1360)-G5-Avi-6His-Flag expressed in baculovirus-infected sf21 cells using His6-SMAD1 as substrate preincubated for 30 mins followed by substrate addition and measured after 120 mins by ADP-Glo Reagent based method	B	CS(=O)(=O)c1ccc(-c2cc(-c3ccc(O)cc3)cnc2N)cc1		CHEMBL3754283	=	IC50	nM	10.0	CHEMBL4527	Homo sapiens	pIC50		8.0
	19452094	CHEMBL4434088	Inhibition of human full length TNIK(1-1360)-G5-Avi-6His-Flag expressed in baculovirus-infected sf21 cells using His6-SMAD1 as substrate preincubated for 30 mins followed by substrate addition and measured after 120 mins by ADP-Glo Reagent based method	B	Fc1cc(-c2ccc3ccncc3n2)ccn1		CHEMBL4558988	=	IC50	nM	5011.87	CHEMBL4527	Homo sapiens	pIC50		5.3
	19452095	CHEMBL4434088	Inhibition of human full length TNIK(1-1360)-G5-Avi-6His-Flag expressed in baculovirus-infected sf21 cells using His6-SMAD1 as substrate preincubated for 30 mins followed by substrate addition and measured after 120 mins by ADP-Glo Reagent based method	B	Nc1ncc(Br)c2ccc(-c3ccnc(F)c3)nc12		CHEMBL4471729	=	IC50	nM	7.943	CHEMBL4527	Homo sapiens	pIC50		8.1
	19452114	CHEMBL4434086	Inhibition of human 6His-TEV-TNIK(1 to 325) expressed in baculovirus-infected sf21 cells using LRRKtide as substrate preincubated for 30 mins followed by substrate addition and measured after 75 to 90 mins by ADP-Glo Reagent based method	B	CC(C)NC(=O)c1ccc(-c2cnc(N(C)C)c(-c3ccc(C#N)cc3)c2)cc1		CHEMBL4465524	=	IC50	nM	25118.86	CHEMBL4527	Homo sapiens	pIC50		4.6
	19452115	CHEMBL4434086	Inhibition of human 6His-TEV-TNIK(1 to 325) expressed in baculovirus-infected sf21 cells using LRRKtide as substrate preincubated for 30 mins followed by substrate addition and measured after 75 to 90 mins by ADP-Glo Reagent based method	B	CC(C)NC(=O)c1ccc(-c2cnc(N)c(-c3ccc(C#N)cc3)c2)cc1		CHEMBL4558962	=	IC50	nM	79.43	CHEMBL4527	Homo sapiens	pIC50		7.1
	19452116	CHEMBL4434086	Inhibition of human 6His-TEV-TNIK(1 to 325) expressed in baculovirus-infected sf21 cells using LRRKtide as substrate preincubated for 30 mins followed by substrate addition and measured after 75 to 90 mins by ADP-Glo Reagent based method	B	CN(C)c1ncc(-c2ccc(O)cc2)cc1-c1ccc(S(C)(=O)=O)cc1		CHEMBL4451091	=	IC50	nM	3981.07	CHEMBL4527	Homo sapiens	pIC50		5.4
	19452117	CHEMBL4434086	Inhibition of human 6His-TEV-TNIK(1 to 325) expressed in baculovirus-infected sf21 cells using LRRKtide as substrate preincubated for 30 mins followed by substrate addition and measured after 75 to 90 mins by ADP-Glo Reagent based method	B	CS(=O)(=O)c1ccc(-c2cc(-c3ccc(O)cc3)cnc2N)cc1		CHEMBL3754283	=	IC50	nM	10.0	CHEMBL4527	Homo sapiens	pIC50		8.0
	19452118	CHEMBL4434086	Inhibition of human 6His-TEV-TNIK(1 to 325) expressed in baculovirus-infected sf21 cells using LRRKtide as substrate preincubated for 30 mins followed by substrate addition and measured after 75 to 90 mins by ADP-Glo Reagent based method	B	Fc1cc(-c2ccc3ccncc3n2)ccn1		CHEMBL4558988	=	IC50	nM	15848.93	CHEMBL4527	Homo sapiens	pIC50		4.8
	19452119	CHEMBL4434086	Inhibition of human 6His-TEV-TNIK(1 to 325) expressed in baculovirus-infected sf21 cells using LRRKtide as substrate preincubated for 30 mins followed by substrate addition and measured after 75 to 90 mins by ADP-Glo Reagent based method	B	Nc1ncnc2ccc(-c3ccnc(F)c3)nc12		CHEMBL3262590	=	IC50	nM	150.0	CHEMBL4527	Homo sapiens	IC50	nM	150.0
	19452120	CHEMBL4434086	Inhibition of human 6His-TEV-TNIK(1 to 325) expressed in baculovirus-infected sf21 cells using LRRKtide as substrate preincubated for 30 mins followed by substrate addition and measured after 75 to 90 mins by ADP-Glo Reagent based method	B	Nc1ncnc2ccc(-c3ccnc(F)c3)nc12		CHEMBL3262590	=	IC50	nM	158.49	CHEMBL4527	Homo sapiens	pIC50		6.8
	19452121	CHEMBL4434086	Inhibition of human 6His-TEV-TNIK(1 to 325) expressed in baculovirus-infected sf21 cells using LRRKtide as substrate preincubated for 30 mins followed by substrate addition and measured after 75 to 90 mins by ADP-Glo Reagent based method	B	Nc1ncc(Br)c2ccc(-c3ccnc(F)c3)nc12		CHEMBL4471729	=	IC50	nM	12.59	CHEMBL4527	Homo sapiens	pIC50		7.9
	19452122	CHEMBL4434086	Inhibition of human 6His-TEV-TNIK(1 to 325) expressed in baculovirus-infected sf21 cells using LRRKtide as substrate preincubated for 30 mins followed by substrate addition and measured after 75 to 90 mins by ADP-Glo Reagent based method	B	CC(C)(O)c1cnc(N)c2nc(-c3ccnc(F)c3)ccc12		CHEMBL4527085	=	IC50	nM	125.89	CHEMBL4527	Homo sapiens	pIC50		6.9
Not Active	19452131	CHEMBL4434083	Inhibition of human TNIK in human iPSC derived neuronal progenitor cells assessed as reduction in motif phosphorylation at 10 uM after 6 hrs with presence of okadaic acid by Western blot analysis	B	CC(C)NC(=O)c1ccc(-c2cnc(N(C)C)c(-c3ccc(C#N)cc3)c2)cc1		CHEMBL4465524		Inhibition	%		CHEMBL4527	Homo sapiens	INH		
Active	19452132	CHEMBL4434083	Inhibition of human TNIK in human iPSC derived neuronal progenitor cells assessed as reduction in motif phosphorylation at 10 uM after 6 hrs with presence of okadaic acid by Western blot analysis	B	CC(C)NC(=O)c1ccc(-c2cnc(N)c(-c3ccc(C#N)cc3)c2)cc1		CHEMBL4558962		Inhibition	%		CHEMBL4527	Homo sapiens	INH		
Not Active	19452133	CHEMBL4434083	Inhibition of human TNIK in human iPSC derived neuronal progenitor cells assessed as reduction in motif phosphorylation at 10 uM after 6 hrs with presence of okadaic acid by Western blot analysis	B	CN(C)c1ncc(-c2ccc(O)cc2)cc1-c1ccc(S(C)(=O)=O)cc1		CHEMBL4451091		Inhibition	%		CHEMBL4527	Homo sapiens	INH		
Active	19452134	CHEMBL4434083	Inhibition of human TNIK in human iPSC derived neuronal progenitor cells assessed as reduction in motif phosphorylation at 10 uM after 6 hrs with presence of okadaic acid by Western blot analysis	B	CS(=O)(=O)c1ccc(-c2cc(-c3ccc(O)cc3)cnc2N)cc1		CHEMBL3754283		Inhibition	%		CHEMBL4527	Homo sapiens	INH		
Not Active	19452135	CHEMBL4434083	Inhibition of human TNIK in human iPSC derived neuronal progenitor cells assessed as reduction in motif phosphorylation at 10 uM after 6 hrs with presence of okadaic acid by Western blot analysis	B	Fc1cc(-c2ccc3ccncc3n2)ccn1		CHEMBL4558988		Inhibition	%		CHEMBL4527	Homo sapiens	INH		
Active	19452136	CHEMBL4434083	Inhibition of human TNIK in human iPSC derived neuronal progenitor cells assessed as reduction in motif phosphorylation at 10 uM after 6 hrs with presence of okadaic acid by Western blot analysis	B	Nc1ncc(Br)c2ccc(-c3ccnc(F)c3)nc12		CHEMBL4471729		Inhibition	%		CHEMBL4527	Homo sapiens	INH		
Not Active	19452137	CHEMBL4434091	Inhibition of human full length TNIK in HEK293 cells co-transfected with full length SMAD1 up to 30 uM incubated for 2 hrs by ELISA	B	CC(C)NC(=O)c1ccc(-c2cnc(N(C)C)c(-c3ccc(C#N)cc3)c2)cc1		CHEMBL4465524		Inhibition	%		CHEMBL4527	Homo sapiens	INH		
Not Active	19452138	CHEMBL4434091	Inhibition of human full length TNIK in HEK293 cells co-transfected with full length SMAD1 up to 30 uM incubated for 2 hrs by ELISA	B	CN(C)c1ncc(-c2ccc(O)cc2)cc1-c1ccc(S(C)(=O)=O)cc1		CHEMBL4451091		Inhibition	%		CHEMBL4527	Homo sapiens	INH		
Not Active	19452139	CHEMBL4434091	Inhibition of human full length TNIK in HEK293 cells co-transfected with full length SMAD1 up to 30 uM incubated for 2 hrs by ELISA	B	Fc1cc(-c2ccc3ccncc3n2)ccn1		CHEMBL4558988		Inhibition	%		CHEMBL4527	Homo sapiens	INH		
	19452140	CHEMBL4434082	Inhibition of human full length TNIK in HEK293 cells co-transfected with full length SMAD1 incubated for 2 hrs by ELISA	B	CC(C)NC(=O)c1ccc(-c2cnc(N(C)C)c(-c3ccc(C#N)cc3)c2)cc1		CHEMBL4465524	<	IC50	nM	31622.78	CHEMBL4527	Homo sapiens	pIC50		4.5
	19452141	CHEMBL4434082	Inhibition of human full length TNIK in HEK293 cells co-transfected with full length SMAD1 incubated for 2 hrs by ELISA	B	CC(C)NC(=O)c1ccc(-c2cnc(N)c(-c3ccc(C#N)cc3)c2)cc1		CHEMBL4558962	=	IC50	nM	1258.93	CHEMBL4527	Homo sapiens	pIC50		5.9
	19452142	CHEMBL4434082	Inhibition of human full length TNIK in HEK293 cells co-transfected with full length SMAD1 incubated for 2 hrs by ELISA	B	CC(C)NC(=O)c1ccc(-c2cnc(N)c(-c3ccc(C#N)cc3)c2)cc1		CHEMBL4558962	=	IC50	nM	930.0	CHEMBL4527	Homo sapiens	IC50	uM	0.93
	19452143	CHEMBL4434082	Inhibition of human full length TNIK in HEK293 cells co-transfected with full length SMAD1 incubated for 2 hrs by ELISA	B	CN(C)c1ncc(-c2ccc(O)cc2)cc1-c1ccc(S(C)(=O)=O)cc1		CHEMBL4451091	<	IC50	nM	31622.78	CHEMBL4527	Homo sapiens	pIC50		4.5
	19452144	CHEMBL4434082	Inhibition of human full length TNIK in HEK293 cells co-transfected with full length SMAD1 incubated for 2 hrs by ELISA	B	CS(=O)(=O)c1ccc(-c2cc(-c3ccc(O)cc3)cnc2N)cc1		CHEMBL3754283	=	IC50	nM	501.19	CHEMBL4527	Homo sapiens	pIC50		6.3
	19452145	CHEMBL4434082	Inhibition of human full length TNIK in HEK293 cells co-transfected with full length SMAD1 incubated for 2 hrs by ELISA	B	CS(=O)(=O)c1ccc(-c2cc(-c3ccc(O)cc3)cnc2N)cc1		CHEMBL3754283	=	IC50	nM	470.0	CHEMBL4527	Homo sapiens	IC50	uM	0.47
	19452146	CHEMBL4434082	Inhibition of human full length TNIK in HEK293 cells co-transfected with full length SMAD1 incubated for 2 hrs by ELISA	B	Fc1cc(-c2ccc3ccncc3n2)ccn1		CHEMBL4558988	<	IC50	nM	31622.78	CHEMBL4527	Homo sapiens	pIC50		4.5
	19452147	CHEMBL4434082	Inhibition of human full length TNIK in HEK293 cells co-transfected with full length SMAD1 incubated for 2 hrs by ELISA	B	Nc1ncc(Br)c2ccc(-c3ccnc(F)c3)nc12		CHEMBL4471729	=	IC50	nM	1258.93	CHEMBL4527	Homo sapiens	pIC50		5.9
	19452148	CHEMBL4434082	Inhibition of human full length TNIK in HEK293 cells co-transfected with full length SMAD1 incubated for 2 hrs by ELISA	B	Nc1ncc(Br)c2ccc(-c3ccnc(F)c3)nc12		CHEMBL4471729	=	IC50	nM	1130.0	CHEMBL4527	Homo sapiens	IC50	uM	1.13
	20598209	CHEMBL4602936	Inhibition of human TNIK	B	c1ccc(-c2nnc(N3CCN(c4ncccn4)CC3)cc2-c2ccncc2)cc1		CHEMBL4632881	<	IC50	nM	1000.0	CHEMBL4527	Homo sapiens	IC50	uM	1.0
	20598210	CHEMBL4602936	Inhibition of human TNIK	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	<	IC50	nM	1000.0	CHEMBL4527	Homo sapiens	IC50	uM	1.0
	20598211	CHEMBL4602936	Inhibition of human TNIK	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	<	IC50	nM	1000.0	CHEMBL4527	Homo sapiens	IC50	uM	1.0
	20691799	CHEMBL4625641	Inhibition of human wild type partial length TNIK (D4-K311 residues) expressed in bacterial expression system	B	CC(C)Nc1cc(Nc2ccn3nccc3n2)ncc1C(=O)NC[C@@H](F)C(C)(C)O		CHEMBL4641090	=	IC50	nM	8.0	CHEMBL4527	Homo sapiens	IC50	nM	8.0
	20691800	CHEMBL4625641	Inhibition of human wild type partial length TNIK (D4-K311 residues) expressed in bacterial expression system	B	CC(C)Nc1cc(Nc2nc3ccnn3cc2F)ncc1C(=O)NC[C@@H](F)C(C)(C)O		CHEMBL4634922	=	IC50	nM	130.0	CHEMBL4527	Homo sapiens	IC50	nM	130.0
Active	20694106	CHEMBL4626199	Inhibition of TNIK (unknown origin)	B	COc1cc(-c2cncc(-c3ccc(C4CCN(C)CC4)cc3)c2C)cc(OC)c1OC		CHEMBL4633241		Inhibition	%		CHEMBL4527	Homo sapiens	INH		
	20694144	CHEMBL4626224	Inhibition of TNIK (unknown origin) at 1 uM relative to control	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(OC)c1F		CHEMBL4636120	>	Inhibition	%	50.0	CHEMBL4527	Homo sapiens	INH	%	50.0
	20694301	CHEMBL4626199	Inhibition of TNIK (unknown origin)	B	COc1cc(-c2cncc(-c3ccc(N4CCNCC4)cc3)c2C)cc(OC)c1OC		CHEMBL4517408	=	IC50	nM	96.0	CHEMBL4527	Homo sapiens	IC50	nM	96.0
	22423185	CHEMBL4674168	Inhibition of human TNIK using RLGRDKYKTLRQIRQ as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	7.09	CHEMBL4527	Homo sapiens	Activity	%	7.09
	22423186	CHEMBL4674168	Inhibition of human TNIK using RLGRDKYKTLRQIRQ as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	0.42	CHEMBL4527	Homo sapiens	Activity	%	0.42
	22445224	CHEMBL4679407	Inhibition of TNIK (unknown origin) by mobility shift assay	B	O[C@H]1CC[C@@H](Oc2cccc3cnc(Nc4ccc5nc[nH]c5c4)nc23)CC1		CHEMBL4776173	=	IC50	nM	21.0	CHEMBL4527	Homo sapiens	IC50	nM	21.0
Dose-dependent effect	22445225	CHEMBL4679408	Inhibition of TNIK in human Jurkat cells assessed as reduction in PMA/anti-CD3 antibody-induced IL2 level incubated for 24 hrs by ELISA	B	CN1CCC(n2cc(-c3cnc4[nH]cc(-c5cc(C#N)c(Cl)c(NS(C)(=O)=O)c5)c4c3)cn2)CC1		CHEMBL4780310		Inhibition	%		CHEMBL4527	Homo sapiens	INH		
Dose-dependent effect	22445226	CHEMBL4679408	Inhibition of TNIK in human Jurkat cells assessed as reduction in PMA/anti-CD3 antibody-induced IL2 level incubated for 24 hrs by ELISA	B	CC(C)(Oc1ccc(-c2cnc3[nH]cc(-c4cc(C#N)cc(NS(C)(=O)=O)c4)c3c2)cc1)C(=O)O		CHEMBL4788688		Inhibition	%		CHEMBL4527	Homo sapiens	INH		
Dose-dependent effect	22445227	CHEMBL4679408	Inhibition of TNIK in human Jurkat cells assessed as reduction in PMA/anti-CD3 antibody-induced IL2 level incubated for 24 hrs by ELISA	B	CC(C)(C(=O)O)c1ccc(-c2cnc3[nH]cc(-c4cc(C#N)cc(NS(C)(=O)=O)c4)c3c2)cc1		CHEMBL4797770		Inhibition	%		CHEMBL4527	Homo sapiens	INH		
Dose-dependent effect	22445228	CHEMBL4679408	Inhibition of TNIK in human Jurkat cells assessed as reduction in PMA/anti-CD3 antibody-induced IL2 level incubated for 24 hrs by ELISA	B	O[C@H]1CC[C@@H](Oc2cccc3cnc(Nc4ccc5nc[nH]c5c4)nc23)CC1		CHEMBL4776173		Inhibition	%		CHEMBL4527	Homo sapiens	INH		
Dose-dependent effect	22445229	CHEMBL4679408	Inhibition of TNIK in human Jurkat cells assessed as reduction in PMA/anti-CD3 antibody-induced IL2 level incubated for 24 hrs by ELISA	B	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5cc(C#N)c(Cl)c(NS(C)(=O)=O)c5)c4c3)cc2)CC1		CHEMBL4760435		Inhibition	%		CHEMBL4527	Homo sapiens	INH		
Dose-dependent effect	22445230	CHEMBL4679408	Inhibition of TNIK in human Jurkat cells assessed as reduction in PMA/anti-CD3 antibody-induced IL2 level incubated for 24 hrs by ELISA	B	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5cc(C#N)cc(NS(=O)(=O)C6CC6)c5)c4c3)cc2)CC1		CHEMBL4759123		Inhibition	%		CHEMBL4527	Homo sapiens	INH		
Dose-dependent effect	22445231	CHEMBL4679408	Inhibition of TNIK in human Jurkat cells assessed as reduction in PMA/anti-CD3 antibody-induced IL2 level incubated for 24 hrs by ELISA	B	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5cc(C#N)cc(NS(C)(=O)=O)c5)c4c3)cc2)CC1		CHEMBL4749291		Inhibition	%		CHEMBL4527	Homo sapiens	INH		
	22445232	CHEMBL4679409	Inhibition of TNIK in PMA/anti-CD3 antibody-stimulated human Jurkat cells assessed as IL2 level at 10 uM incubated for 24 hrs by ELISA	B	CN1CCC(n2cc(-c3cnc4[nH]cc(-c5cc(C#N)c(Cl)c(NS(C)(=O)=O)c5)c4c3)cn2)CC1		CHEMBL4780310	<	Activity	pg/ml	25.0	CHEMBL4527	Homo sapiens	Activity	pg/ml	25.0
	22445233	CHEMBL4679409	Inhibition of TNIK in PMA/anti-CD3 antibody-stimulated human Jurkat cells assessed as IL2 level at 10 uM incubated for 24 hrs by ELISA	B	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5cc(C#N)c6[nH]ncc6c5)c4c3)cc2)CC1		CHEMBL4797452	<	Activity	pg/ml	25.0	CHEMBL4527	Homo sapiens	Activity	pg/ml	25.0
	22445234	CHEMBL4679409	Inhibition of TNIK in PMA/anti-CD3 antibody-stimulated human Jurkat cells assessed as IL2 level at 10 uM incubated for 24 hrs by ELISA	B	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5cc(C#N)cc(NS(=O)(=O)C6CC6)c5)c4c3)cc2)CC1		CHEMBL4759123	<	Activity	pg/ml	25.0	CHEMBL4527	Homo sapiens	Activity	pg/ml	25.0
	22445235	CHEMBL4679409	Inhibition of TNIK in PMA/anti-CD3 antibody-stimulated human Jurkat cells assessed as IL2 level at 10 uM incubated for 24 hrs by ELISA	B	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5cc(C#N)cc(NS(C)(=O)=O)c5)c4c3)cc2)CC1		CHEMBL4749291	<	Activity	pg/ml	25.0	CHEMBL4527	Homo sapiens	Activity	pg/ml	25.0
Not Active	22445236	CHEMBL4679410	Inhibition of TNIK in human Jurkat cells assessed as reduction in PMA/anti-CD3 antibody-induced IL2 secretion at 1 uM incubated for 24 hrs by ELISA	B	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5cc(C#N)c6[nH]ncc6c5)c4c3)cc2)CC1		CHEMBL4797452		Inhibition	%		CHEMBL4527	Homo sapiens	INH		
	22445237	CHEMBL4679411	Inhibition of TNIK (unknown origin)	B	c1ccc(-c2cnc3[nH]cc(-c4ccccc4)c3c2)cc1		CHEMBL3102859	=	IC50	nM	9.2	CHEMBL4527	Homo sapiens	IC50	nM	9.2
	22445238	CHEMBL4679411	Inhibition of TNIK (unknown origin)	B	CN1CCC(n2cc(-c3cnc4[nH]cc(-c5cc(C#N)c(Cl)c(NS(C)(=O)=O)c5)c4c3)cn2)CC1		CHEMBL4780310	=	IC50	nM	0.68	CHEMBL4527	Homo sapiens	IC50	nM	0.68
	22445239	CHEMBL4679411	Inhibition of TNIK (unknown origin)	B	CNC(=O)c1cccc(-c2cnc3[nH]cc(-c4cc(C#N)c(Cl)c(NS(C)(=O)=O)c4)c3c2)c1		CHEMBL4756005	=	IC50	nM	0.3	CHEMBL4527	Homo sapiens	IC50	nM	0.3
	22445240	CHEMBL4679411	Inhibition of TNIK (unknown origin)	B	Cn1cc(-c2ccc(-c3cnc4[nH]cc(-c5cc(C#N)cc(NS(C)(=O)=O)c5)c4c3)cc2)cn1		CHEMBL4781043	=	IC50	nM	0.8	CHEMBL4527	Homo sapiens	IC50	nM	0.8
	22445241	CHEMBL4679411	Inhibition of TNIK (unknown origin)	B	CC(C)(Oc1ccc(-c2cnc3[nH]cc(-c4cc(C#N)cc(NS(C)(=O)=O)c4)c3c2)cc1)C(=O)O		CHEMBL4788688	=	IC50	nM	0.33	CHEMBL4527	Homo sapiens	IC50	nM	0.33
	22445242	CHEMBL4679411	Inhibition of TNIK (unknown origin)	B	CC(C)(C(=O)O)c1ccc(-c2cnc3[nH]cc(-c4cc(C#N)cc(NS(C)(=O)=O)c4)c3c2)cc1		CHEMBL4797770	=	IC50	nM	0.47	CHEMBL4527	Homo sapiens	IC50	nM	0.47
	22445243	CHEMBL4679411	Inhibition of TNIK (unknown origin)	B	CS(=O)(=O)Nc1cc(C#N)cc(-c2c[nH]c3ncc(-c4cccc(C(=O)N5CCCCC5)c4)cc23)c1		CHEMBL4788405	=	IC50	nM	0.22	CHEMBL4527	Homo sapiens	IC50	nM	0.22
	22445244	CHEMBL4679411	Inhibition of TNIK (unknown origin)	B	CN(C)C1CCN(C(=O)c2cccc(-c3cnc4[nH]cc(-c5cc(C#N)cc(NS(C)(=O)=O)c5)c4c3)c2)C1		CHEMBL4788976	=	IC50	nM	0.22	CHEMBL4527	Homo sapiens	IC50	nM	0.22
	22445245	CHEMBL4679411	Inhibition of TNIK (unknown origin)	B	CS(=O)(=O)Nc1cc(C#N)cc(-c2c[nH]c3ncc(-c4cccc(C(=O)N5CCCC5)c4)cc23)c1		CHEMBL4744045	=	IC50	nM	0.21	CHEMBL4527	Homo sapiens	IC50	nM	0.21
	22445246	CHEMBL4679411	Inhibition of TNIK (unknown origin)	B	CS(=O)(=O)Nc1cc(C#N)cc(-c2c[nH]c3ncc(-c4cccc(C(=O)NC5CC5)c4)cc23)c1		CHEMBL4760558	=	IC50	nM	0.12	CHEMBL4527	Homo sapiens	IC50	nM	0.12
	22445247	CHEMBL4679411	Inhibition of TNIK (unknown origin)	B	CNC(=O)c1cccc(-c2cnc3[nH]cc(-c4cc(C#N)cc(NS(C)(=O)=O)c4)c3c2)c1		CHEMBL4762464	=	IC50	nM	0.18	CHEMBL4527	Homo sapiens	IC50	nM	0.18
	22445248	CHEMBL4679411	Inhibition of TNIK (unknown origin)	B	CN1CCN(C(=O)c2cccc(-c3cnc4[nH]cc(-c5cc(C#N)cc(NS(C)(=O)=O)c5)c4c3)c2)CC1		CHEMBL4791330	=	IC50	nM	0.25	CHEMBL4527	Homo sapiens	IC50	nM	0.25
	22445249	CHEMBL4679411	Inhibition of TNIK (unknown origin)	B	CN1CCN(C(=O)c2ccc(-c3cnc4[nH]cc(-c5cc(C#N)cc(NS(C)(=O)=O)c5)c4c3)cc2)CC1		CHEMBL4751494	=	IC50	nM	0.21	CHEMBL4527	Homo sapiens	IC50	nM	0.21
	22445250	CHEMBL4679411	Inhibition of TNIK (unknown origin)	B	O[C@H]1CC[C@@H](Oc2cccc3cnc(Nc4ccc5nc[nH]c5c4)nc23)CC1		CHEMBL4776173	=	IC50	nM	16.6	CHEMBL4527	Homo sapiens	IC50	nM	16.6
	22445251	CHEMBL4679411	Inhibition of TNIK (unknown origin)	B	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5cc(C#N)c6[nH]ncc6c5)c4c3)cc2)CC1		CHEMBL4797452	=	IC50	nM	0.23	CHEMBL4527	Homo sapiens	IC50	nM	0.23
	22445252	CHEMBL4679411	Inhibition of TNIK (unknown origin)	B	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5cnc6[nH]ncc6c5)c4c3)cc2)CC1		CHEMBL4741790	=	IC50	nM	7.9	CHEMBL4527	Homo sapiens	IC50	nM	7.9
	22445253	CHEMBL4679411	Inhibition of TNIK (unknown origin)	B	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5ccc6[nH]cnc6c5)c4c3)cc2)CC1		CHEMBL4778005	=	IC50	nM	3.8	CHEMBL4527	Homo sapiens	IC50	nM	3.8
	22445254	CHEMBL4679411	Inhibition of TNIK (unknown origin)	B	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5ccc6[nH]ncc6c5)c4c3)cc2)CC1		CHEMBL4754003	=	IC50	nM	0.44	CHEMBL4527	Homo sapiens	IC50	nM	0.44
	22445255	CHEMBL4679411	Inhibition of TNIK (unknown origin)	B	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5cccc6ccccc56)c4c3)cc2)CC1		CHEMBL4745045	=	IC50	nM	31.0	CHEMBL4527	Homo sapiens	IC50	nM	31.0
	22445256	CHEMBL4679411	Inhibition of TNIK (unknown origin)	B	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5ccc6[nH]ccc6c5)c4c3)cc2)CC1		CHEMBL2436978	=	IC50	nM	5.2	CHEMBL4527	Homo sapiens	IC50	nM	5.2
	22445257	CHEMBL4679411	Inhibition of TNIK (unknown origin)	B	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5cc(C#N)c(Cl)c(NS(C)(=O)=O)c5)c4c3)cc2)CC1		CHEMBL4760435	=	IC50	nM	0.43	CHEMBL4527	Homo sapiens	IC50	nM	0.43
	22445258	CHEMBL4679411	Inhibition of TNIK (unknown origin)	B	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5cc(C#N)cc(NS(=O)(=O)C6CC6)c5)c4c3)cc2)CC1		CHEMBL4759123	=	IC50	nM	0.19	CHEMBL4527	Homo sapiens	IC50	nM	0.19
	22445259	CHEMBL4679411	Inhibition of TNIK (unknown origin)	B	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5cc(C#N)cc(NS(C)(=O)=O)c5)c4c3)cc2)CC1		CHEMBL4749291	=	IC50	nM	0.13	CHEMBL4527	Homo sapiens	IC50	nM	0.13
	22445260	CHEMBL4679411	Inhibition of TNIK (unknown origin)	B	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5ccc(NS(C)(=O)=O)cc5)c4c3)cc2)CC1		CHEMBL4749390	=	IC50	nM	18.0	CHEMBL4527	Homo sapiens	IC50	nM	18.0
	22445261	CHEMBL4679411	Inhibition of TNIK (unknown origin)	B	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5cccc(NS(C)(=O)=O)c5)c4c3)cc2)CC1		CHEMBL4758384	=	IC50	nM	7.1	CHEMBL4527	Homo sapiens	IC50	nM	7.1
	22445262	CHEMBL4679411	Inhibition of TNIK (unknown origin)	B	CC(=O)Nc1cccc(-c2c[nH]c3ncc(-c4ccc(CN5CCN(C)CC5)cc4)cc23)c1		CHEMBL4795159	=	IC50	nM	12.0	CHEMBL4527	Homo sapiens	IC50	nM	12.0
	22445263	CHEMBL4679411	Inhibition of TNIK (unknown origin)	B	CNC(=O)c1cccc(-c2c[nH]c3ncc(-c4ccc(CN5CCN(C)CC5)cc4)cc23)c1		CHEMBL4761756	=	IC50	nM	27.0	CHEMBL4527	Homo sapiens	IC50	nM	27.0
	22445264	CHEMBL4679411	Inhibition of TNIK (unknown origin)	B	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5cccc(C(=O)N(C)C)c5)c4c3)cc2)CC1		CHEMBL4746089	=	IC50	nM	43.0	CHEMBL4527	Homo sapiens	IC50	nM	43.0
	22445265	CHEMBL4679411	Inhibition of TNIK (unknown origin)	B	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5cccc(N)c5)c4c3)cc2)CC1		CHEMBL4787455	=	IC50	nM	15.0	CHEMBL4527	Homo sapiens	IC50	nM	15.0
	22445266	CHEMBL4679411	Inhibition of TNIK (unknown origin)	B	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5cccc(C#N)c5)c4c3)cc2)CC1		CHEMBL4743105	=	IC50	nM	0.91	CHEMBL4527	Homo sapiens	IC50	nM	0.91
	22445267	CHEMBL4679411	Inhibition of TNIK (unknown origin)	B	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5ccc(F)cc5)c4c3)cc2)CC1		CHEMBL4798207	=	IC50	nM	19.0	CHEMBL4527	Homo sapiens	IC50	nM	19.0
	22445268	CHEMBL4679411	Inhibition of TNIK (unknown origin)	B	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5ccc(Cl)cc5)c4c3)cc2)CC1		CHEMBL4757719	=	IC50	nM	14.0	CHEMBL4527	Homo sapiens	IC50	nM	14.0
	22445269	CHEMBL4679411	Inhibition of TNIK (unknown origin)	B	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5ccccc5)c4c3)cc2)CC1		CHEMBL4753491	=	IC50	nM	14.0	CHEMBL4527	Homo sapiens	IC50	nM	14.0
	22445270	CHEMBL4679412	Inhibition of GST-tagged human TNIK kinase domain (1 to 314 residues) expressed in baculovirus-infected Sf21 cells using FITC-epsilon-aminocaproic acid-Lys-Tyr-Lys-Thr-Leu-Arg-Gln as substrate incubated for 1 hr in presence of ATP by ATP competitive assay	B	Cc1ccc(C(=O)Nc2sc(Nc3ccccc3)nc2C(N)=O)cc1		CHEMBL3764451	=	Ki	nM	100.0	CHEMBL4527	Homo sapiens	Ki	nM	100.0
	22455687	CHEMBL4681967	Inhibition of TNIK (unknown origin) in presence of 10 uM ATP	B	CC(C)(Oc1ccc(-c2cnc(N)c(-c3ccc(Cl)cc3)c2)cc1)C(=O)O		CHEMBL4746566	<	IC50	nM	0.6	CHEMBL4527	Homo sapiens	IC50	nM	0.6
	22455693	CHEMBL4681973	Inhibition of TNIK in human PBMC lysates at 1 uM by ActivX screen assay relative to control	B	CC(C)(Oc1ccc(-c2cnc(N)c(-c3ccc(Cl)cc3)c2)cc1)C(=O)O		CHEMBL4746566	>	Inhibition	%	70.0	CHEMBL4527	Homo sapiens	INH	%	70.0
	22843540	CHEMBL4720526	Inhibition of human TNIK using RLGRDKYKTLRQIRQ as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.314	CHEMBL4527	Homo sapiens	IC50	10^-10M	3.14
	22843881	CHEMBL4720867	Inhibition of human TNIK assessed as residual activity using RLGRDKYKTLRQIRQ as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	87.63	CHEMBL4527	Homo sapiens	Activity	%	87.63
	22844936	CHEMBL4721611	Inhibition of wild-type human partial length TNIK (D4 to K311 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	98.43	CHEMBL4527	Homo sapiens	Activity	%	98.43
	22953020	CHEMBL4766957	Inhibition of human TNIK (1 to 367 residues) assessed as residual activity at 10 uM using RLGRDKYKTLRQIRQ as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	5.0	CHEMBL4527	Homo sapiens	Activity	%	5.0
	22953104	CHEMBL4767041	Inhibition of human TNIK (1 to 367 residues) using RLGRDKYKTLRQIRQ as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	IC50	nM	221.0	CHEMBL4527	Homo sapiens	IC50	uM	0.221
	23121169	CHEMBL4804515	Inhibition of TNIK in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	IC50	nM	97000.0	CHEMBL4527	Homo sapiens	IC50	uM	97.0
	23121170	CHEMBL4804515	Inhibition of TNIK in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	IC50	nM	94500.0	CHEMBL4527	Homo sapiens	IC50	uM	94.5
	23121171	CHEMBL4804515	Inhibition of TNIK in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	IC50	nM	57600.0	CHEMBL4527	Homo sapiens	IC50	uM	57.6
	23121172	CHEMBL4804515	Inhibition of TNIK in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	IC50	nM	97200.0	CHEMBL4527	Homo sapiens	IC50	uM	97.2
	23121173	CHEMBL4804515	Inhibition of TNIK in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	IC50	nM	66600.0	CHEMBL4527	Homo sapiens	IC50	uM	66.6
	23121174	CHEMBL4804515	Inhibition of TNIK in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	IC50	nM	96700.0	CHEMBL4527	Homo sapiens	IC50	uM	96.7
	23122207	CHEMBL4804697	Inhibition of TNIK in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	>	Inhibition	%	90.0	CHEMBL4527	Homo sapiens	INH	%	90.0
	23122208	CHEMBL4804697	Inhibition of TNIK in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	>	Inhibition	%	90.0	CHEMBL4527	Homo sapiens	INH	%	90.0
	23122209	CHEMBL4804697	Inhibition of TNIK in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	>	Inhibition	%	90.0	CHEMBL4527	Homo sapiens	INH	%	90.0
	23122210	CHEMBL4804697	Inhibition of TNIK in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	>	Inhibition	%	90.0	CHEMBL4527	Homo sapiens	INH	%	90.0
	23122211	CHEMBL4804697	Inhibition of TNIK in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	50.0	CHEMBL4527	Homo sapiens	INH	%	50.0
	23122212	CHEMBL4804697	Inhibition of TNIK in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	>	Inhibition	%	90.0	CHEMBL4527	Homo sapiens	INH	%	90.0
	23122846	CHEMBL4805197	Inhibition of human TNIK assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	89.0	CHEMBL4527	Homo sapiens	Activity	%	89.0
	23123541	CHEMBL4805785	Inhibition of human TNIK assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	98.0	CHEMBL4527	Homo sapiens	Activity	%	98.0
	23123993	CHEMBL4806237	Inhibition of DNA-tagged human TNIK assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	100.0	CHEMBL4527	Homo sapiens	Activity	%	100.0
	23125172	CHEMBL4806802	Inhibition of human TNIK assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL4527	Homo sapiens	Activity	%	100.0
	23125173	CHEMBL4806802	Inhibition of human TNIK assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	91.0	CHEMBL4527	Homo sapiens	Activity	%	91.0
	23287849	CHEMBL4838726	Inhibition of N-terminal GST-tagged TNIK (1 to 314 residues) (unknown origin) cytoplasmic domain expressed in Sf21 cells	B	CCC[C@H](C)Nc1ncc2c(C3CCN(C(=O)c4cc(C)nc(C)c4)CC3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4877347	=	IC50	nM	67.7	CHEMBL4527	Homo sapiens	IC50	nM	67.7
	23287850	CHEMBL4838726	Inhibition of N-terminal GST-tagged TNIK (1 to 314 residues) (unknown origin) cytoplasmic domain expressed in Sf21 cells	B	CCC[C@H](C)Nc1ncc2c(-c3ccc(CN4CCCN(C)CC4)cc3)cn([C@H]3CC[C@H](O)CC3)c2n1		CHEMBL4283353	=	IC50	nM	5.8	CHEMBL4527	Homo sapiens	IC50	nM	5.8
Not Active	23317682	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	93.0	CHEMBL4527	Homo sapiens	% Control	%	93.0
Not Active	23318150	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	96.0	CHEMBL4527	Homo sapiens	% Control	%	96.0
Not Active	23318816	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	81.0	CHEMBL4527	Homo sapiens	% Control	%	81.0
Not Active	23319300	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	99.0	CHEMBL4527	Homo sapiens	% Control	%	99.0
Not Active	23319936	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23320412	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	86.0	CHEMBL4527	Homo sapiens	% Control	%	86.0
Not Active	23321090	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23321558	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23322188	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	88.0	CHEMBL4527	Homo sapiens	% Control	%	88.0
Not Active	23322656	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23323345	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	71.0	CHEMBL4527	Homo sapiens	% Control	%	71.0
Not Active	23323813	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23324667	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23325302	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	84.0	CHEMBL4527	Homo sapiens	% Control	%	84.0
Not Active	23325770	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	93.0	CHEMBL4527	Homo sapiens	% Control	%	93.0
Not Active	23326417	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	93.0	CHEMBL4527	Homo sapiens	% Control	%	93.0
Not Active	23326885	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23327585	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23328053	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	71.0	CHEMBL4527	Homo sapiens	% Control	%	71.0
Not Active	23328640	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	92.0	CHEMBL4527	Homo sapiens	% Control	%	92.0
Not Active	23329108	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	98.0	CHEMBL4527	Homo sapiens	% Control	%	98.0
Not Active	23329555	CHEMBL4881262	TNIK(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	89.0	CHEMBL4527	Homo sapiens	% residual kinase activity	%	89.0
Not Active	23330054	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23330522	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23331278	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	75.0	CHEMBL4527	Homo sapiens	% Control	%	75.0
Not Active	23331746	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	99.0	CHEMBL4527	Homo sapiens	% Control	%	99.0
Not Active	23332333	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	97.4	CHEMBL4527	Homo sapiens	% Control	%	97.4
Not Active	23332799	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23333517	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	90.8	CHEMBL4527	Homo sapiens	% Control	%	90.8
Not Active	23334156	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	85.0	CHEMBL4527	Homo sapiens	% Control	%	85.0
Not Active	23334624	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	99.0	CHEMBL4527	Homo sapiens	% Control	%	99.0
Not Active	23335603	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23336071	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	96.0	CHEMBL4527	Homo sapiens	% Control	%	96.0
Not Active	23336698	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	98.0	CHEMBL4527	Homo sapiens	% Control	%	98.0
Not Active	23337166	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23338247	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23338715	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23339327	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23339795	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	97.0	CHEMBL4527	Homo sapiens	% Control	%	97.0
Not Active	23340432	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	95.0	CHEMBL4527	Homo sapiens	% Control	%	95.0
Not Active	23340900	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23341557	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23342025	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	68.0	CHEMBL4527	Homo sapiens	% Control	%	68.0
Not Active	23342641	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23343109	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23343739	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23344207	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	97.0	CHEMBL4527	Homo sapiens	% Control	%	97.0
Not Active	23344845	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23345418	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	96.0	CHEMBL4527	Homo sapiens	% Control	%	96.0
Not Active	23345886	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	78.0	CHEMBL4527	Homo sapiens	% Control	%	78.0
Not Active	23346462	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23346931	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	75.8	CHEMBL4527	Homo sapiens	% Control	%	75.8
Not Active	23347530	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	95.8	CHEMBL4527	Homo sapiens	% Control	%	95.8
Not Active	23348023	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23348602	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23349070	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	93.0	CHEMBL4527	Homo sapiens	% Control	%	93.0
Not Active	23349657	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	82.0	CHEMBL4527	Homo sapiens	% Control	%	82.0
Not Active	23350275	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	94.0	CHEMBL4527	Homo sapiens	% Control	%	94.0
Not Active	23350743	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	81.0	CHEMBL4527	Homo sapiens	% Control	%	81.0
Not Active	23351348	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	79.0	CHEMBL4527	Homo sapiens	% Control	%	79.0
Not Active	23351816	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23352840	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23353308	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	80.0	CHEMBL4527	Homo sapiens	% Control	%	80.0
Not Active	23354190	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23354658	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23355390	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23355858	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23356494	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23356962	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23357571	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	95.0	CHEMBL4527	Homo sapiens	% Control	%	95.0
Not Active	23358218	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23358686	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	92.0	CHEMBL4527	Homo sapiens	% Control	%	92.0
Not Active	23359272	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23359870	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23360338	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	56.0	CHEMBL4527	Homo sapiens	% Control	%	56.0
Not Active	23360923	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23361391	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23361964	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23362500	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23362968	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23364610	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23365078	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23365817	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	83.0	CHEMBL4527	Homo sapiens	% Control	%	83.0
Not Active	23366360	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23366950	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23367418	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23368296	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23368764	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23369363	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	96.0	CHEMBL4527	Homo sapiens	% Control	%	96.0
Not Active	23369831	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	53.0	CHEMBL4527	Homo sapiens	% Control	%	53.0
Not Active	23370264	CHEMBL4884503	TNIK(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	49.0	CHEMBL4527	Homo sapiens	% residual kinase activity	%	49.0
Not Active	23370799	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	78.0	CHEMBL4527	Homo sapiens	% Control	%	78.0
Not Active	23371267	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	98.0	CHEMBL4527	Homo sapiens	% Control	%	98.0
Not Active	23372076	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Slightly Active	23372544	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	45.0	CHEMBL4527	Homo sapiens	% Control	%	45.0
	23372917	CHEMBL4884882	TNIK [ZC2(TNIKLGF1)] Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL4527	Homo sapiens	pIC50		6.0
	23373326	CHEMBL4885173	TNIK [ZC2(TNIKLGF1)] Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL4527	Homo sapiens	pIC50		6.0
	23373680	CHEMBL4885457	TNIK [ZC2(TNIKLGF1)] Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL4527	Homo sapiens	pIC50		6.0
Not Active	23375971	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23376439	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	99.0	CHEMBL4527	Homo sapiens	% Control	%	99.0
Not Active	23377016	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	83.0	CHEMBL4527	Homo sapiens	% Control	%	83.0
Not Active	23377484	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23378344	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	93.0	CHEMBL4527	Homo sapiens	% Control	%	93.0
Not Active	23378812	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	87.0	CHEMBL4527	Homo sapiens	% Control	%	87.0
Not Active	23379979	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23380447	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23381141	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	61.0	CHEMBL4527	Homo sapiens	% Control	%	61.0
Not Active	23381789	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23382257	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23382881	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	65.0	CHEMBL4527	Homo sapiens	% Control	%	65.0
Not Active	23383349	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	77.0	CHEMBL4527	Homo sapiens	% Control	%	77.0
Not Active	23383677	CHEMBL4887333	TNIK Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	99.0	CHEMBL4527	Homo sapiens	% Ctrl	%	99.0
Not Active	23384493	CHEMBL4888088	TNIK(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O	Outside typical range	CHEMBL4802045		Inhibition	%	-14.85	CHEMBL4527	Homo sapiens	% inhibition	%	-14.85
Not Active	23385263	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
Not Active	23385731	CHEMBL4879988	KinomeScan assay: inhibition of TNIK	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	100.0	CHEMBL4527	Homo sapiens	% Control	%	100.0
